CPT_id	classType	ui	suppressible	obsolete	rootSource	atomCount	cVMemberCount	attributes	atoms	ancestors	parents	children	descendants	relations	definitions	concepts	defaultPreferredAtom	name
0004M	SourceAtomCluster	0004M	False	False	CPT	4	0					NONE	NONE		NONE	C3869478;C5697507		Scoliosis, DNA analysis of 53 single nucleotide polymorphisms (SNPs), using saliva, prognostic algorithm reported as a risk score
0006M	SourceAtomCluster	0006M	False	False	CPT	4	0					NONE	NONE		NONE	C3869477;C5697508		Oncology (hepatic), mRNA expression levels of 161 genes, utilizing fresh hepatocellular carcinoma tumor tissue, with alpha-fetoprotein level, algorithm reported as a risk classifier
0007M	SourceAtomCluster	0007M	False	False	CPT	4	0					NONE	NONE		NONE	C3869476;C5697509		Oncology (gastrointestinal neuroendocrine tumors), real-time PCR expression analysis of 51 genes, utilizing whole peripheral blood, algorithm reported as a nomogram of tumor disease index
0011M	SourceAtomCluster	0011M	False	False	CPT	4	0					NONE	NONE		NONE	C4732724;C5697510		Oncology, prostate cancer, mRNA expression assay of 12 genes (10 content and 2 housekeeping), RT-PCR test utilizing blood plasma and urine, algorithms to predict high-grade prostate cancer risk
0012M	SourceAtomCluster	0012M	False	False	CPT	4	0					NONE	NONE		NONE	C5697511;C4732725		Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having urothelial carcinoma
0013M	SourceAtomCluster	0013M	False	False	CPT	4	0					NONE	NONE		NONE	C5697512;C4732726		Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having recurrent urothelial carcinoma
0016M	SourceAtomCluster	0016M	False	False	CPT	4	0					NONE	NONE		NONE	C5697515;C5416727		Oncology (bladder), mRNA, microarray gene expression profiling of 219 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as molecular subtype (luminal, luminal infiltrated, basal, basal claudin-low, neuroendocrine-like)
0017M	SourceAtomCluster	0017M	False	False	CPT	4	0					NONE	NONE		NONE	C5691641;C5697516		Oncology (diffuse large B-cell lymphoma [DLBCL]), mRNA, gene expression profiling by fluorescent probe hybridization of 20 genes, formalin-fixed paraffin-embedded tissue, algorithm reported as cell of origin
0020M	SourceAtomCluster	0020M	False	False	CPT	4	0					NONE	NONE		NONE	C5945048;C5945047		Oncology (central nervous system), analysis of 30000 DNA methylation loci by methylation array, utilizing DNA extracted from tumor tissue, diagnostic algorithm reported as probability of matching a reference tumor subclass
0001U	SourceAtomCluster	0001U	False	False	CPT	5	0					NONE	NONE		NONE	C4521667;C5414375;C4301946		Red blood cell antigen typing, DNA, human erythrocyte antigen gene analysis of 35 antigens from 11 blood groups, utilizing whole blood, common RBC alleles reported
0005U	SourceAtomCluster	0005U	False	False	CPT	5	0					NONE	NONE		NONE	C4521662;C5414377		Oncology (prostate) gene expression profile by real-time RT-PCR of 3 genes (ERG, PCA3, and SPDEF), urine, algorithm reported as risk score
0007U	SourceAtomCluster	0007U	False	False	CPT	5	0					NONE	NONE		NONE	C4521675;C4523580		Drug test(s), presumptive, with definitive confirmation of positive results, any number of drug classes, urine, includes specimen verification including DNA authentication in comparison to buccal DNA, per date of service
0008U	SourceAtomCluster	0008U	False	False	CPT	7	0					NONE	NONE		NONE	C4521495;C5414379;C5414380;C5414378		Helicobacter pylori detection and antibiotic resistance, DNA, 16S and 23S rRNA, gyrA, pbp1, rdxA and rpoB, next generation sequencing, formalin-fixed paraffin-embedded or fresh tissue or fecal sample, predictive, reported as positive or negative for resistance to clarithromycin, fluoroquinolones, metronidazole, amoxicillin, tetracycline, and rifabutin
0009U	SourceAtomCluster	0009U	False	False	CPT	5	0					NONE	NONE		NONE	C4521499;C4521655;C5414381		Oncology (breast cancer), ERBB2 (HER2) copy number by FISH, tumor cells from formalin-fixed paraffin-embedded tissue isolated using image-based dielectrophoresis (DEP) sorting, reported as ERBB2 gene amplified or non-amplified
0010U	SourceAtomCluster	0010U	False	False	CPT	5	0					NONE	NONE		NONE	C4521498;C0201216;C5414382		Infectious disease (bacterial), strain typing by whole genome sequencing, phylogenetic-based report of strain relatedness, per submitted isolate
0016U	SourceAtomCluster	0016U	False	False	CPT	6	0					NONE	NONE		NONE	C4521658;C5414388;C5414389;C5414387		Oncology (hematolymphoid neoplasia), RNA, BCR/ABL1 major and minor breakpoint fusion transcripts, quantitative PCR amplification, blood or bone marrow, report of fusion not detected or detected with quantitation
0017U	SourceAtomCluster	0017U	False	False	CPT	6	0					NONE	NONE		NONE	C5414392;C4521657;C5414390;C5414391		Oncology (hematolymphoid neoplasia), JAK2 mutation, DNA, PCR amplification of exons 12-14 and sequence analysis, blood or bone marrow, report of JAK2 mutation not detected or detected
0018U	SourceAtomCluster	0018U	False	False	CPT	5	0					NONE	NONE		NONE	C4542814;C5414393;C4732273		Oncology (thyroid), microRNA profiling by RT-PCR of 10 microRNA sequences, utilizing fine needle aspirate, algorithm reported as a positive or negative result for moderate to high risk of malignancy
0019U	SourceAtomCluster	0019U	False	False	CPT	6	0					NONE	NONE		NONE	C4732277;C4542815;C4732275;C4732276		Oncology, RNA, gene expression by whole transcriptome sequencing, formalin-fixed paraffin-embedded tissue or fresh frozen tissue, predictive algorithm reported as potential targets for therapeutic agents
0022U	SourceAtomCluster	0022U	False	False	CPT	5	0					NONE	NONE		NONE	C5851832;C4542817;C5851833		Targeted genomic sequence analysis panel, non-small cell lung neoplasia, DNA and RNA analysis, 23 genes, interrogation for sequence variants and rearrangements, reported as presence or absence of variants and associated therapy(ies) to consider
0023U	SourceAtomCluster	0023U	False	False	CPT	5	0					NONE	NONE		NONE	C4542818;C5414395;C4732283		Oncology (acute myelogenous leukemia), DNA, genotyping of internal tandem duplication, p.D835, p.I836, using mononuclear cells, reported as detection or non-detection of FLT3 mutation and indication for or against the use of midostaurin
0026U	SourceAtomCluster	0026U	False	False	CPT	5	0					NONE	NONE		NONE	C4732291;C4732292;C5414398		Oncology (thyroid), DNA and mRNA of 112 genes, next-generation sequencing, fine needle aspirate of thyroid nodule, algorithmic analysis reported as a categorical result ("Positive, high probability of malignancy" or "Negative, low probability of malignancy")
0027U	SourceAtomCluster	0027U	False	False	CPT	5	0					NONE	NONE		NONE	C4732294;C4732295;C5414399		JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, targeted sequence analysis exons 12-15
0029U	SourceAtomCluster	0029U	False	False	CPT	5	0					NONE	NONE		NONE	C4732298;C4732299;C5414400		Drug metabolism (adverse drug reactions and drug response), targeted sequence analysis (ie, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP4F2, SLCO1B1, VKORC1 and rs12777823)
0030U	SourceAtomCluster	0030U	False	False	CPT	5	0					NONE	NONE		NONE	C4732302;C4732301;C5414401		Drug metabolism (warfarin drug response), targeted sequence analysis (ie, CYP2C9, CYP4F2, VKORC1, rs12777823)
0031U	SourceAtomCluster	0031U	False	False	CPT	5	0					NONE	NONE		NONE	C4732305;C4732304;C4722651		CYP1A2 (cytochrome P450 family 1, subfamily A, member 2) (eg, drug metabolism) gene analysis, common variants (ie, *1F, *1K, *6, *7)
0032U	SourceAtomCluster	0032U	False	False	CPT	5	0					NONE	NONE		NONE	C4724362;C4732307;C4732306		COMT (catechol-O-methyltransferase) (eg, drug metabolism) gene analysis, c.472G>A (rs4680) variant
0033U	SourceAtomCluster	0033U	False	False	CPT	5	0					NONE	NONE		NONE	C4732309;C4732310;C4732308		HTR2A (5-hydroxytryptamine receptor 2A), HTR2C (5-hydroxytryptamine receptor 2C) (eg, citalopram metabolism) gene analysis, common variants (ie, HTR2A rs7997012 [c.614-2211T>C], HTR2C rs3813929 [c.-759C>T] and rs1414334 [c.551-3008C>G])
0034U	SourceAtomCluster	0034U	False	False	CPT	5	0					NONE	NONE		NONE	C4732311;C4732312;C3708795		TPMT (thiopurine S-methyltransferase), NUDT15 (nudix hydroxylase 15) (eg, thiopurine metabolism) gene analysis, common variants (ie, TPMT *2, *3A, *3B, *3C, *4, *5, *6, *8, *12; NUDT15 *3, *4, *5)
0036U	SourceAtomCluster	0036U	False	False	CPT	5	0					NONE	NONE		NONE	C4732318;C4732316;C4732317		Exome (ie, somatic mutations), paired formalin-fixed paraffin-embedded tumor tissue and normal specimen, sequence analyses
0037U	SourceAtomCluster	0037U	False	False	CPT	5	0					NONE	NONE		NONE	C4732319;C4732320;C4732321		Targeted genomic sequence analysis, solid organ neoplasm, DNA analysis of 324 genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden
0040U	SourceAtomCluster	0040U	False	False	CPT	5	0					NONE	NONE		NONE	C4732326;C5414403;C4732327		BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis, major breakpoint, quantitative
0045U	SourceAtomCluster	0045U	False	False	CPT	5	0					NONE	NONE		NONE	C4732341;C4732340;C5414407		Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence score
0046U	SourceAtomCluster	0046U	False	False	CPT	5	0					NONE	NONE		NONE	C4732343;C5414408;C3516223		FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia) internal tandem duplication (ITD) variants, quantitative
0047U	SourceAtomCluster	0047U	False	False	CPT	5	0					NONE	NONE		NONE	C4732345;C5414409;C4732346		Oncology (prostate), mRNA, gene expression profiling by real-time RT-PCR of 17 genes (12 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a risk score
0048U	SourceAtomCluster	0048U	False	False	CPT	5	0					NONE	NONE		NONE	C4732348;C4732349;C5414410		Oncology (solid organ neoplasia), DNA, targeted sequencing of protein-coding exons of 468 cancer-associated genes, including interrogation for somatic mutations and microsatellite instability, matched with normal specimens, utilizing formalin-fixed paraffin-embedded tumor tissue, report of clinically significant mutation(s)
0049U	SourceAtomCluster	0049U	False	False	CPT	5	0					NONE	NONE		NONE	C4732352;C4732351;C4732353		NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative
0050U	SourceAtomCluster	0050U	False	False	CPT	5	0					NONE	NONE		NONE	C4732356;C4732354;C4732355		Targeted genomic sequence analysis panel, acute myelogenous leukemia, DNA analysis, 194 genes, interrogation for sequence variants, copy number variants or rearrangements
0055U	SourceAtomCluster	0055U	False	False	CPT	5	0					NONE	NONE		NONE	C4732370;C4732371;C5414414		Cardiology (heart transplant), cell-free DNA, PCR assay of 96 DNA target sequences (94 single nucleotide polymorphism targets and two control targets), plasma
0060U	SourceAtomCluster	0060U	False	False	CPT	5	0					NONE	NONE		NONE	C4732385;C4732384;C5414417		Twin zygosity, genomic-targeted sequence analysis of chromosome 2, using circulating cell-free fetal DNA in maternal blood
0068U	SourceAtomCluster	0068U	False	False	CPT	5	0					NONE	NONE		NONE	C5202026;C4746528;C5202027		Candida species panel (C. albicans, C. glabrata, C. parapsilosis, C. kruseii, C. tropicalis, and C. auris), amplified probe technique with qualitative report of the presence or absence of each species
0069U	SourceAtomCluster	0069U	False	False	CPT	5	0					NONE	NONE		NONE	C5202028;C5414423;C4746529		Oncology (colorectal), microRNA, RT-PCR expression profiling of miR-31-3p, formalin-fixed paraffin-embedded tissue, algorithm reported as an expression score
0070U	SourceAtomCluster	0070U	False	False	CPT	5	0					NONE	NONE		NONE	C5202030;C4746530;C5202031		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, common and select rare variants (ie, *2, *3, *4, *4N, *5, *6, *7, *8, *9, *10, *11, *12, *13, *14A, *14B, *15, *17, *29, *35, *36, *41, *57, *61, *63, *68, *83, *xN)
0071U	SourceAtomCluster	0071U	False	False	CPT	5	0					NONE	NONE		NONE	C5201275;C5202033;C5202032		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, full gene sequence (List separately in addition to code for primary procedure)
0072U	SourceAtomCluster	0072U	False	False	CPT	5	0					NONE	NONE		NONE	C5414424;C4746531;C5202034		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D6-2D7 hybrid gene) (List separately in addition to code for primary procedure)
0073U	SourceAtomCluster	0073U	False	False	CPT	5	0					NONE	NONE		NONE	C5202036;C5414425;C4746532		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, CYP2D7-2D6 hybrid gene) (List separately in addition to code for primary procedure)
0074U	SourceAtomCluster	0074U	False	False	CPT	5	0					NONE	NONE		NONE	C4746533;C5202038;C5414426		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, non-duplicated gene when duplication/multiplication is trans) (List separately in addition to code for primary procedure)
0075U	SourceAtomCluster	0075U	False	False	CPT	5	0					NONE	NONE		NONE	C5202040;C4746534;C5414427		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 5' gene duplication/multiplication) (List separately in addition to code for primary procedure)
0076U	SourceAtomCluster	0076U	False	False	CPT	5	0					NONE	NONE		NONE	C5202042;C5202041;C4746535		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, targeted sequence analysis (ie, 3' gene duplication/multiplication) (List separately in addition to code for primary procedure)
0078U																		
0079U	SourceAtomCluster	0079U	False	False	CPT	5	0					NONE	NONE		NONE	C4746538;C5202048;C5202049		Comparative DNA analysis using multiple selected single-nucleotide polymorphisms (SNPs), urine and buccal DNA, for specimen identity verification
0084U	SourceAtomCluster	0084U	False	False	CPT	5	0					NONE	NONE		NONE	C5202059;C5202058;C5202060		Red blood cell antigen typing, DNA, genotyping of 10 blood groups with phenotype prediction of 37 red blood cell antigens
0086U	SourceAtomCluster	0086U	False	False	CPT	5	0					NONE	NONE		NONE	C5202066;C5202067;C5202065		Infectious disease (bacterial and fungal), organism identification, blood culture, using rRNA FISH, 6 or more organism targets, reported as positive or negative with phenotypic minimum inhibitory concentration (MIC)-based antimicrobial susceptibility
0087U	SourceAtomCluster	0087U	False	False	CPT	5	0					NONE	NONE		NONE	C5202070;C5202071;C5202072		Cardiology (heart transplant), mRNA gene expression profiling by microarray of 1283 genes, transplant biopsy tissue, allograft rejection and injury algorithm reported as a probability score
0088U	SourceAtomCluster	0088U	False	False	CPT	5	0					NONE	NONE		NONE	C5202074;C5202073;C5202075		Transplantation medicine (kidney allograft rejection), microarray gene expression profiling of 1494 genes, utilizing transplant biopsy tissue, algorithm reported as a probability score for rejection
0089U	SourceAtomCluster	0089U	False	False	CPT	5	0					NONE	NONE		NONE	C5202076;C5414433;C5202077		Oncology (melanoma), gene expression profiling by RTqPCR, PRAME and LINC00518, superficial collection using adhesive patch(es)
0090U	SourceAtomCluster	0090U	False	False	CPT	5	0					NONE	NONE		NONE	C5202081;C5202080		Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 23 genes (14 content and 9 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)
0094U	SourceAtomCluster	0094U	False	False	CPT	7	0					NONE	NONE		NONE	C5202093;C5202092;C5202094;C5202095		Genome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis
0096U	SourceAtomCluster	0096U	False	False	CPT	5	0					NONE	NONE		NONE	C5202100;C5202099;C5202101		Human papillomavirus (HPV), high-risk types (ie, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68), male urine
0101U	SourceAtomCluster	0101U	False	False	CPT	5	0					NONE	NONE		NONE	C5202114;C5202115;C5414441		Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (15 genes [sequencing and deletion/duplication], EPCAM and GREM1 [deletion/duplication only])
0102U	SourceAtomCluster	0102U	False	False	CPT	5	0					NONE	NONE		NONE	C5202117;C5202118;C5414442		Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (17 genes [sequencing and deletion/duplication])
0103U	SourceAtomCluster	0103U	False	False	CPT	5	0					NONE	NONE		NONE	C5202120;C5202121;C5414443		Hereditary ovarian cancer (eg, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis panel utilizing a combination of NGS, Sanger, MLPA, and array CGH, with mRNA analytics to resolve variants of unknown significance when indicated (24 genes [sequencing and deletion/duplication], EPCAM [deletion/duplication only])
0109U	SourceAtomCluster	0109U	False	False	CPT	7	0					NONE	NONE		NONE	C5202138;C5414451;C5414452;C5202139;C5414453		Infectious disease (Aspergillus species), real-time PCR for detection of DNA from 4 species (A. fumigatus, A. terreus, A. niger, and A. flavus), blood, lavage fluid, or tissue, qualitative reporting of presence or absence of each species
0111U	SourceAtomCluster	0111U	False	False	CPT	5	0					NONE	NONE		NONE	C5202154;C5414470;C5202153		Oncology (colon cancer), targeted KRAS (codons 12, 13, and 61) and NRAS (codons 12, 13, and 61) gene analysis, utilizing formalin-fixed paraffin-embedded tissue
0112U	SourceAtomCluster	0112U	False	False	CPT	5	0					NONE	NONE		NONE	C5202157;C5202156;C5414471		Infectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance gene
0113U	SourceAtomCluster	0113U	False	False	CPT	5	0					NONE	NONE		NONE	C5202159;C5202160;C5202161		Oncology (prostate), measurement of PCA3 and TMPRSS2-ERG in urine and PSA in serum following prostatic massage, by RNA amplification and fluorescence-based detection, algorithm reported as risk score
0114U	SourceAtomCluster	0114U	False	False	CPT	5	0					NONE	NONE		NONE	C5202162;C5202164;C5202163		Gastroenterology (Barrett's esophagus), VIM and CCNA1 methylation analysis, esophageal cells, algorithm reported as likelihood for Barrett's esophagus
0118U	SourceAtomCluster	0118U	False	False	CPT	5	0					NONE	NONE		NONE	C5202174;C5202176;C5202175		Transplantation medicine, quantification of donor-derived cell-free DNA using whole genome next-generation sequencing, plasma, reported as percentage of donor-derived cell-free DNA in the total cell-free DNA
0120U	SourceAtomCluster	0120U	False	False	CPT	5	0					NONE	NONE		NONE	C5202182;C5202180;C5202181		Oncology (B-cell lymphoma classification), mRNA, gene expression profiling by fluorescent probe hybridization of 58 genes (45 content and 13 housekeeping genes), formalin-fixed paraffin-embedded tissue, algorithm reported as likelihood for primary mediastinal B-cell lymphoma (PMBCL) and diffuse large B-cell lymphoma (DLBCL) with cell of origin subtyping in the latter
0129U	SourceAtomCluster	0129U	False	False	CPT	5	0					NONE	NONE		NONE	C5202208;C5202207;C5414477		Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), genomic sequence analysis and deletion/duplication analysis panel (ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, and TP53)
0130U	SourceAtomCluster	0130U	False	False	CPT	5	0					NONE	NONE		NONE	C5202211;C5202210;C5414478		Hereditary colon cancer disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), targeted mRNA sequence analysis panel (APC, CDH1, CHEK2, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN, and TP53) (List separately in addition to code for primary procedure)
0131U	SourceAtomCluster	0131U	False	False	CPT	5	0					NONE	NONE		NONE	C5202215;C5202213;C5202214		Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), targeted mRNA sequence analysis panel (13 genes) (List separately in addition to code for primary procedure)
0132U	SourceAtomCluster	0132U	False	False	CPT	5	0					NONE	NONE		NONE	C5202216;C5202217;C5414479		Hereditary ovarian cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer), targeted mRNA sequence analysis panel (17 genes) (List separately in addition to code for primary procedure)
0133U	SourceAtomCluster	0133U	False	False	CPT	5	0					NONE	NONE		NONE	C5202219;C5202220;C5414480		Hereditary prostate cancer-related disorders, targeted mRNA sequence analysis panel (11 genes) (List separately in addition to code for primary procedure)
0134U	SourceAtomCluster	0134U	False	False	CPT	5	0					NONE	NONE		NONE	C5202222;C5202223;C5414481		Hereditary pan cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (18 genes) (List separately in addition to code for primary procedure)
0135U	SourceAtomCluster	0135U	False	False	CPT	5	0					NONE	NONE		NONE	C5202225;C5202226;C5414482		Hereditary gynecological cancer (eg, hereditary breast and ovarian cancer, hereditary endometrial cancer, hereditary colorectal cancer), targeted mRNA sequence analysis panel (12 genes) (List separately in addition to code for primary procedure)
0136U	SourceAtomCluster	0136U	False	False	CPT	5	0					NONE	NONE		NONE	C5202228;C5202229;C5202230		ATM (ataxia telangiectasia mutated) (eg, ataxia telangiectasia) mRNA sequence analysis (List separately in addition to code for primary procedure)
0137U	SourceAtomCluster	0137U	False	False	CPT	5	0					NONE	NONE		NONE	C5202231;C5202232;C5414483		PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)
0138U	SourceAtomCluster	0138U	False	False	CPT	5	0					NONE	NONE		NONE	C5202235;C5202234;C5414484		BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) mRNA sequence analysis (List separately in addition to code for primary procedure)
0140U	SourceAtomCluster	0140U	False	False	CPT	5	0					NONE	NONE		NONE	C5229224;C5414487;C5414488		Infectious disease (fungi), fungal pathogen identification, DNA (15 fungal targets), blood culture, amplified probe technique, each target reported as detected or not detected
0141U	SourceAtomCluster	0141U	False	False	CPT	5	0					NONE	NONE		NONE	C5229225;C5414489;C5414490		Infectious disease (bacteria and fungi), gram-positive organism identification and drug resistance element detection, DNA (20 gram-positive bacterial targets, 4 resistance genes, 1 pan gram-negative bacterial target, 1 pan Candida target), blood culture, amplified probe technique, each target reported as detected or not detected
0142U	SourceAtomCluster	0142U	False	False	CPT	5	0					NONE	NONE		NONE	C5414491;C5414492;C5229226		Infectious disease (bacteria and fungi), gram-negative bacterial identification and drug resistance element detection, DNA (21 gram-negative bacterial targets, 6 resistance genes, 1 pan gram-positive bacterial target, 1 pan Candida target), amplified probe technique, each target reported as detected or not detected
0152U	SourceAtomCluster	0152U	False	False	CPT	5	0					NONE	NONE		NONE	C5229235;C5698180;C5696561		Infectious disease (bacteria, fungi, parasites, and DNA viruses), microbial cell-free DNA, plasma, untargeted next-generation sequencing, report for significant positive pathogens
0153U	SourceAtomCluster	0153U	False	False	CPT	5	0					NONE	NONE		NONE	C5229236;C5414514;C5414513		Oncology (breast), mRNA, gene expression profiling by next-generation sequencing of 101 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a triple negative breast cancer clinical subtype(s) with information on immune cell involvement
0154U	SourceAtomCluster	0154U	False	False	CPT	5	0					NONE	NONE		NONE	C5414515;C5414516;C5414517		Oncology (urothelial cancer), RNA, analysis by real-time RT-PCR of the FGFR3 (fibroblast growth factor receptor 3) gene analysis (ie, p.R248C [c.742C>T], p.S249C [c.746C>G], p.G370C [c.1108G>T], p.Y373C [c.1118A>G], FGFR3-TACC3v1, and FGFR3-TACC3v3), utilizing formalin-fixed paraffin-embedded urothelial cancer tumor tissue, reported as FGFR gene alteration status
0155U	SourceAtomCluster	0155U	False	False	CPT	5	0					NONE	NONE		NONE	C5414518;C5414520;C5414519		Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, breast cancer) gene analysis (ie, p.C420R, p.E542K, p.E545A, p.E545D [g.1635G>T only], p.E545G, p.E545K, p.Q546E, p.Q546R, p.H1047L, p.H1047R, p.H1047Y), utilizing formalin-fixed paraffin-embedded breast tumor tissue, reported as PIK3CA gene mutation status
0156U	SourceAtomCluster	0156U	False	False	CPT	5	0					NONE	NONE		NONE	C5414521;C5414522;C5229239		Copy number (eg, intellectual disability, dysmorphology), sequence analysis
0157U	SourceAtomCluster	0157U	False	False	CPT	5	0					NONE	NONE		NONE	C5225015;C5414523;C5414524		APC (APC regulator of WNT signaling pathway) (eg, familial adenomatosis polyposis [FAP]) mRNA sequence analysis (List separately in addition to code for primary procedure)
0158U	SourceAtomCluster	0158U	False	False	CPT	5	0					NONE	NONE		NONE	C5225017;C5414525;C5414526		MLH1 (mutL homolog 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0159U	SourceAtomCluster	0159U	False	False	CPT	5	0					NONE	NONE		NONE	C5225018;C5414527;C5414528		MSH2 (mutS homolog 2) (eg, hereditary colon cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0160U	SourceAtomCluster	0160U	False	False	CPT	5	0					NONE	NONE		NONE	C5225019;C5414530;C5414529		MSH6 (mutS homolog 6) (eg, hereditary colon cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0161U	SourceAtomCluster	0161U	False	False	CPT	5	0					NONE	NONE		NONE	C5229244;C5414532;C5414531		PMS2 (PMS1 homolog 2, mismatch repair system component) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) mRNA sequence analysis (List separately in addition to code for primary procedure)
0162U	SourceAtomCluster	0162U	False	False	CPT	5	0					NONE	NONE		NONE	C5414533;C5229245;C5414534		Hereditary colon cancer (Lynch syndrome), targeted mRNA sequence analysis panel (MLH1, MSH2, MSH6, PMS2) (List separately in addition to code for primary procedure)
0169U	SourceAtomCluster	0169U	False	False	CPT	5	0					NONE	NONE		NONE	C5414553;C5414554;C5414555		NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants
0170U	SourceAtomCluster	0170U	False	False	CPT	5	0					NONE	NONE		NONE	C5414556;C5414558;C5414557		Neurology (autism spectrum disorder [ASD]), RNA, next-generation sequencing, saliva, algorithmic analysis, and results reported as predictive probability of ASD diagnosis
0171U	SourceAtomCluster	0171U	False	False	CPT	5	0					NONE	NONE		NONE	C5414559;C5414561;C5414560		Targeted genomic sequence analysis panel, acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms, DNA analysis, 23 genes, interrogation for sequence variants, rearrangements and minimal residual disease, reported as presence/absence
0172U	SourceAtomCluster	0172U	False	False	CPT	5	0					NONE	NONE		NONE	C5414563;C5414562;C5414564		Oncology (solid tumor as indicated by the label), somatic mutation analysis of BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) and analysis of homologous recombination deficiency pathways, DNA, formalin-fixed paraffin-embedded tissue, algorithm quantifying tumor genomic instability score
0173U	SourceAtomCluster	0173U	False	False	CPT	5	0					NONE	NONE		NONE	C5414565;C5414567;C5414566		Psychiatry (ie, depression, anxiety), genomic analysis panel, includes variant analysis of 14 genes
0175U	SourceAtomCluster	0175U	False	False	CPT	5	0					NONE	NONE		NONE	C5414571;C5414573;C5414572		Psychiatry (eg, depression, anxiety), genomic analysis panel, variant analysis of 15 genes
0177U	SourceAtomCluster	0177U	False	False	CPT	5	0					NONE	NONE		NONE	C5414575;C5414576;C5414577		Oncology (breast cancer), DNA, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) gene analysis of 11 gene variants utilizing plasma, reported as PIK3CA gene mutation status
0179U	SourceAtomCluster	0179U	False	False	CPT	5	0					NONE	NONE		NONE	C5414581;C5414583;C5414582		Oncology (non-small cell lung cancer), cell-free DNA, targeted sequence analysis of 23 genes (single nucleotide variations, insertions and deletions, fusions without prior knowledge of partner/breakpoint, copy number variations), with report of significant mutation(s)
0180U	SourceAtomCluster	0180U	False	False	CPT	5	0					NONE	NONE		NONE	C5414586;C5414584;C5414585		Red cell antigen (ABO blood group) genotyping (ABO), gene analysis Sanger/chain termination/conventional sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene, including subtyping, 7 exons
0181U	SourceAtomCluster	0181U	False	False	CPT	5	0					NONE	NONE		NONE	C5414587;C5414588;C5414589		Red cell antigen (Colton blood group) genotyping (CO), gene analysis, AQP1 (aquaporin 1 [Colton blood group]) exon 1
0182U	SourceAtomCluster	0182U	False	False	CPT	5	0					NONE	NONE		NONE	C5414590;C5414592;C5414591		Red cell antigen (Cromer blood group) genotyping (CROM), gene analysis, CD55 (CD55 molecule [Cromer blood group]) exons 1-10
0183U	SourceAtomCluster	0183U	False	False	CPT	5	0					NONE	NONE		NONE	C5414595;C5414593;C5414594		Red cell antigen (Diego blood group) genotyping (DI), gene analysis, SLC4A1 (solute carrier family 4 member 1 [Diego blood group]) exon 19
0184U	SourceAtomCluster	0184U	False	False	CPT	5	0					NONE	NONE		NONE	C5414596;C5414597;C5414598		Red cell antigen (Dombrock blood group) genotyping (DO), gene analysis, ART4 (ADP-ribosyltransferase 4 [Dombrock blood group]) exon 2
0185U	SourceAtomCluster	0185U	False	False	CPT	5	0					NONE	NONE		NONE	C5414601;C5414599;C5414600		Red cell antigen (H blood group) genotyping (FUT1), gene analysis, FUT1 (fucosyltransferase 1 [H blood group]) exon 4
0186U	SourceAtomCluster	0186U	False	False	CPT	5	0					NONE	NONE		NONE	C5414602;C5414604;C5414603		Red cell antigen (H blood group) genotyping (FUT2), gene analysis, FUT2 (fucosyltransferase 2) exon 2
0187U	SourceAtomCluster	0187U	False	False	CPT	5	0					NONE	NONE		NONE	C5414605;C5414606;C5414607		Red cell antigen (Duffy blood group) genotyping (FY), gene analysis, ACKR1 (atypical chemokine receptor 1 [Duffy blood group]) exons 1-2
0188U	SourceAtomCluster	0188U	False	False	CPT	5	0					NONE	NONE		NONE	C5414608;C5414609;C5414610		Red cell antigen (Gerbich blood group) genotyping (GE), gene analysis, GYPC (glycophorin C [Gerbich blood group]) exons 1-4
0189U	SourceAtomCluster	0189U	False	False	CPT	5	0					NONE	NONE		NONE	C5414612;C5414611;C5414613		Red cell antigen (MNS blood group) genotyping (GYPA), gene analysis, GYPA (glycophorin A [MNS blood group]) introns 1, 5, exon 2
0190U	SourceAtomCluster	0190U	False	False	CPT	5	0					NONE	NONE		NONE	C5414614;C5414615;C5414616		Red cell antigen (MNS blood group) genotyping (GYPB), gene analysis, GYPB (glycophorin B [MNS blood group]) introns 1, 5, pseudoexon 3
0191U	SourceAtomCluster	0191U	False	False	CPT	5	0					NONE	NONE		NONE	C5414619;C5414617;C5414618		Red cell antigen (Indian blood group) genotyping (IN), gene analysis, CD44 (CD44 molecule [Indian blood group]) exons 2, 3, 6
0192U	SourceAtomCluster	0192U	False	False	CPT	5	0					NONE	NONE		NONE	C5414620;C5414622;C5414621		Red cell antigen (Kidd blood group) genotyping (JK), gene analysis, SLC14A1 (solute carrier family 14 member 1 [Kidd blood group]) gene promoter, exon 9
0193U	SourceAtomCluster	0193U	False	False	CPT	5	0					NONE	NONE		NONE	C5414623;C5414624;C5414625		Red cell antigen (JR blood group) genotyping (JR), gene analysis, ABCG2 (ATP binding cassette subfamily G member 2 [Junior blood group]) exons 2-26
0194U	SourceAtomCluster	0194U	False	False	CPT	5	0					NONE	NONE		NONE	C5414626;C5414627;C5414628		Red cell antigen (Kell blood group) genotyping (KEL), gene analysis, KEL (Kell metallo-endopeptidase [Kell blood group]) exon 8
0195U	SourceAtomCluster	0195U	False	False	CPT	6	0					NONE	NONE		NONE	C5414629;C5414631;C5414632;C5414630		KLF1 (Kruppel-like factor 1), targeted sequencing (ie, exon 13)
0196U	SourceAtomCluster	0196U	False	False	CPT	5	0					NONE	NONE		NONE	C5414633;C5414634;C5414635		Red cell antigen (Lutheran blood group) genotyping (LU), gene analysis, BCAM (basal cell adhesion molecule [Lutheran blood group]) exon 3
0197U	SourceAtomCluster	0197U	False	False	CPT	5	0					NONE	NONE		NONE	C5414636;C5414638;C5414637		Red cell antigen (Landsteiner-Wiener blood group) genotyping (LW), gene analysis, ICAM4 (intercellular adhesion molecule 4 [Landsteiner-Wiener blood group]) exon 1
0198U	SourceAtomCluster	0198U	False	False	CPT	5	0					NONE	NONE		NONE	C5414641;C5414639;C5414640		Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis Sanger/chain termination/conventional sequencing, RHD (Rh blood group D antigen) exons 1-10 and RHCE (Rh blood group CcEe antigens) exon 5
0199U	SourceAtomCluster	0199U	False	False	CPT	5	0					NONE	NONE		NONE	C5414642;C5414643;C5414644		Red cell antigen (Scianna blood group) genotyping (SC), gene analysis, ERMAP (erythroblast membrane associated protein [Scianna blood group]) exons 4, 12
0200U	SourceAtomCluster	0200U	False	False	CPT	5	0					NONE	NONE		NONE	C5414645;C5414646;C5414647		Red cell antigen (Kx blood group) genotyping (XK), gene analysis, XK (X-linked Kx blood group) exons 1-3
0201U	SourceAtomCluster	0201U	False	False	CPT	5	0					NONE	NONE		NONE	C5414649;C5414650;C5414648		Red cell antigen (Yt blood group) genotyping (YT), gene analysis, ACHE (acetylcholinesterase [Cartwright blood group]) exon 2
0203U	SourceAtomCluster	0203U	False	False	CPT	5	0					NONE	NONE		NONE	C5414654;C5414655;C5414653		Autoimmune (inflammatory bowel disease), mRNA, gene expression profiling by quantitative RT-PCR, 17 genes (15 target and 2 reference genes), whole blood, reported as a continuous risk score and classification of inflammatory bowel disease aggressiveness
0205U	SourceAtomCluster	0205U	False	False	CPT	5	0					NONE	NONE		NONE	C5414659;C5414660;C5414661		Ophthalmology (age-related macular degeneration), analysis of 3 gene variants (2 CFH gene, 1 ARMS2 gene), using PCR and MALDI-TOF, buccal swab, reported as positive or negative for neovascular age-related macular-degeneration risk associated with zinc supplements
0209U	SourceAtomCluster	0209U	False	False	CPT	5	0					NONE	NONE		NONE	C5414671;C5414672;C5414673		Cytogenomic constitutional (genome-wide) analysis, interrogation of genomic regions for copy number, structural changes and areas of homozygosity for chromosomal abnormalities
0211U	SourceAtomCluster	0211U	False	False	CPT	5	0					NONE	NONE		NONE	C5414677;C5414678;C5414679		Oncology (pan-tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association
0212U	SourceAtomCluster	0212U	False	False	CPT	6	0					NONE	NONE		NONE	C5414681;C5414680;C5414683;C5414682		Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband
0213U	SourceAtomCluster	0213U	False	False	CPT	8	0					NONE	NONE		NONE	C5414689;C5414684;C5414685;C5414686;C5414688;C5414687		Rare diseases (constitutional/heritable disorders), whole genome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent, sibling)
0214U	SourceAtomCluster	0214U	False	False	CPT	6	0					NONE	NONE		NONE	C5414691;C5414690;C5414693;C5414692		Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, proband
0215U	SourceAtomCluster	0215U	False	False	CPT	8	0					NONE	NONE		NONE	C5414696;C5414697;C5414698;C5414694;C5414699;C5414695		Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator exome (eg, parent, sibling)
0216U	SourceAtomCluster	0216U	False	False	CPT	6	0					NONE	NONE		NONE	C5414701;C5414702;C5414703;C5414700		Neurology (inherited ataxias), genomic DNA sequence analysis of 12 common genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants
0217U	SourceAtomCluster	0217U	False	False	CPT	6	0					NONE	NONE		NONE	C5414704;C5414707;C5414705;C5414706		Neurology (inherited ataxias), genomic DNA sequence analysis of 51 genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants
0218U	SourceAtomCluster	0218U	False	False	CPT	6	0					NONE	NONE		NONE	C5414708;C5414709;C5414710;C5414711		Neurology (muscular dystrophy), DMD gene sequence analysis, including small sequence changes, deletions, duplications, and variants in non-uniquely mappable regions, blood or saliva, identification and characterization of genetic variants
0219U	SourceAtomCluster	0219U	False	False	CPT	5	0					NONE	NONE		NONE	C5414713;C5414714;C5414712		Infectious agent (human immunodeficiency virus), targeted viral next-generation sequence analysis (ie, protease [PR], reverse transcriptase [RT], integrase [INT]), algorithm reported as prediction of antiviral drug susceptibility
0221U	SourceAtomCluster	0221U	False	False	CPT	5	0					NONE	NONE		NONE	C5414718;C5414719;C5414720		Red cell antigen (ABO blood group) genotyping (ABO), gene analysis, next-generation sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene
0222U	SourceAtomCluster	0222U	False	False	CPT	5	0					NONE	NONE		NONE	C5414721;C5414722;C5414723		Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis, next-generation sequencing, RH proximal promoter, exons 1-10, portions of introns 2-3
0227U	SourceAtomCluster	0227U	False	False	CPT	5	0					NONE	NONE		NONE	C5439855;C5698181;C5696562		Drug assay, presumptive, 30 or more drugs or metabolites, urine, liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring (MRM), with drug or metabolite description, includes sample validation
0229U	SourceAtomCluster	0229U	False	False	CPT	5	0					NONE	NONE		NONE	C5439857		BCAT1 (Branched chain amino acid transaminase 1) and IKZF1 (IKAROS family zinc finger 1) (eg, colorectal cancer) promoter methylation analysis
0215U	SourceAtomCluster	0215U	False	False	CPT	8	0					NONE	NONE		NONE	C5414696;C5414697;C5414698;C5414694;C5414699;C5414695		Rare diseases (constitutional/heritable disorders), whole exome and mitochondrial DNA sequence analysis, including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants, each comparator exome (eg, parent, sibling)
0216U	SourceAtomCluster	0216U	False	False	CPT	6	0					NONE	NONE		NONE	C5414701;C5414702;C5414703;C5414700		Neurology (inherited ataxias), genomic DNA sequence analysis of 12 common genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants
0217U	SourceAtomCluster	0217U	False	False	CPT	6	0					NONE	NONE		NONE	C5414704;C5414707;C5414705;C5414706		Neurology (inherited ataxias), genomic DNA sequence analysis of 51 genes including small sequence changes, deletions, duplications, short tandem repeat gene expansions, and variants in non-uniquely mappable regions, blood or saliva, identification and categorization of genetic variants
0218U	SourceAtomCluster	0218U	False	False	CPT	6	0					NONE	NONE		NONE	C5414708;C5414709;C5414710;C5414711		Neurology (muscular dystrophy), DMD gene sequence analysis, including small sequence changes, deletions, duplications, and variants in non-uniquely mappable regions, blood or saliva, identification and characterization of genetic variants
0219U	SourceAtomCluster	0219U	False	False	CPT	5	0					NONE	NONE		NONE	C5414713;C5414714;C5414712		Infectious agent (human immunodeficiency virus), targeted viral next-generation sequence analysis (ie, protease [PR], reverse transcriptase [RT], integrase [INT]), algorithm reported as prediction of antiviral drug susceptibility
0221U	SourceAtomCluster	0221U	False	False	CPT	5	0					NONE	NONE		NONE	C5414718;C5414719;C5414720		Red cell antigen (ABO blood group) genotyping (ABO), gene analysis, next-generation sequencing, ABO (ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase) gene
0222U	SourceAtomCluster	0222U	False	False	CPT	5	0					NONE	NONE		NONE	C5414721;C5414722;C5414723		Red cell antigen (RH blood group) genotyping (RHD and RHCE), gene analysis, next-generation sequencing, RH proximal promoter, exons 1-10, portions of introns 2-3
0227U	SourceAtomCluster	0227U	False	False	CPT	5	0					NONE	NONE		NONE	C5439855;C5698181;C5696562		Drug assay, presumptive, 30 or more drugs or metabolites, urine, liquid chromatography with tandem mass spectrometry (LC-MS/MS) using multiple reaction monitoring (MRM), with drug or metabolite description, includes sample validation
0229U	SourceAtomCluster	0229U	False	False	CPT	5	0					NONE	NONE		NONE	C5439857		BCAT1 (Branched chain amino acid transaminase 1) and IKZF1 (IKAROS family zinc finger 1) (eg, colorectal cancer) promoter methylation analysis
0230U	SourceAtomCluster	0230U	False	False	CPT	5	0					NONE	NONE		NONE	C5698184;C5439858;C5696565		AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation), full sequence analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions
0231U	SourceAtomCluster	0231U	False	False	CPT	5	0					NONE	NONE		NONE	C5439859;C5698185;C5696566		CACNA1A (calcium voltage-gated channel subunit alpha 1A) (eg, spinocerebellar ataxia), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) gene expansions, mobile element insertions, and variants in non-uniquely mappable regions
0232U	SourceAtomCluster	0232U	False	False	CPT	5	0					NONE	NONE		NONE	C5696567;C5439860;C5698186		CSTB (cystatin B) (eg, progressive myoclonic epilepsy type 1A, Unverricht-Lundborg disease), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions
0233U	SourceAtomCluster	0233U	False	False	CPT	5	0					NONE	NONE		NONE	C5575053;C5698187;C5696568		FXN (frataxin) (eg, Friedreich ataxia), gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, short tandem repeat (STR) expansions, mobile element insertions, and variants in non-uniquely mappable regions
0234U	SourceAtomCluster	0234U	False	False	CPT	5	0					NONE	NONE		NONE	C5439861;C5696569;C5698188		MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0235U	SourceAtomCluster	0235U	False	False	CPT	5	0					NONE	NONE		NONE	C5439862;C5698189;C5696570		PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome), full gene analysis, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0236U	SourceAtomCluster	0236U	False	False	CPT	5	0					NONE	NONE		NONE	C5439863;C5696571;C5698190		SMN1 (survival of motor neuron 1, telomeric) and SMN2 (survival of motor neuron 2, centromeric) (eg, spinal muscular atrophy) full gene analysis, including small sequence changes in exonic and intronic regions, duplications, deletions, and mobile element insertions
0237U	SourceAtomCluster	0237U	False	False	CPT	5	0					NONE	NONE		NONE	C5439864;C5696572;C5698191		Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia), genomic sequence analysis panel including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0238U	SourceAtomCluster	0238U	False	False	CPT	5	0					NONE	NONE		NONE	C5439865;C5696573;C5698192		Oncology (Lynch syndrome), genomic DNA sequence analysis of MLH1, MSH2, MSH6, PMS2, and EPCAM, including small sequence changes in exonic and intronic regions, deletions, duplications, mobile element insertions, and variants in non-uniquely mappable regions
0239U	SourceAtomCluster	0239U	False	False	CPT	5	0					NONE	NONE		NONE	C5439866;C5696574;C5698193		Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free DNA, analysis of 311 or more genes, interrogation for sequence variants, including substitutions, insertions, deletions, select rearrangements, and copy number variations
0242U	SourceAtomCluster	0242U	False	False	CPT	5	0					NONE	NONE		NONE	C5696577;C5698196;C5691504		Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 55-74 genes, interrogation for sequence variants, gene copy number amplifications, and gene rearrangements
0244U	SourceAtomCluster	0244U	False	False	CPT	5	0					NONE	NONE		NONE	C5691506;C5698198;C5696579		Oncology (solid organ), DNA, comprehensive genomic profiling, 257 genes, interrogation for single-nucleotide variants, insertions/deletions, copy number alterations, gene rearrangements, tumor-mutational burden and microsatellite instability, utilizing formalin-fixed paraffin-embedded tumor tissue
0245U	SourceAtomCluster	0245U	False	False	CPT	5	0					NONE	NONE		NONE	C5691507;C5696580;C5698199		Oncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes associated risk of malignancy expressed as a percentage
0250U	SourceAtomCluster	0250U	False	False	CPT	5	0					NONE	NONE		NONE	C5691512;C5698204;C5696585		Oncology (solid organ neoplasm), targeted genomic sequence DNA analysis of 505 genes, interrogation for somatic alterations (SNVs [single nucleotide variant], small insertions and deletions, one amplification, and four translocations), microsatellite instability and tumor-mutation burden
0252U	SourceAtomCluster	0252U	False	False	CPT	5	0					NONE	NONE		NONE	C5691513;C5696587;C5698207		Fetal aneuploidy short tandem-repeat comparative analysis, fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy
0253U	SourceAtomCluster	0253U	False	False	CPT	5	0					NONE	NONE		NONE	C5691514;C5696588;C5698208		Reproductive medicine (endometrial receptivity analysis), RNA gene expression profile, 238 genes by next-generation sequencing, endometrial tissue, predictive algorithm reported as endometrial window of implantation (eg, pre-receptive, receptive, post-receptive)
0254U	SourceAtomCluster	0254U	False	False	CPT	5	0					NONE	NONE		NONE	C5691515;C5696589;C5698209		Reproductive medicine (preimplantation genetic assessment), analysis of 24 chromosomes using embryonic DNA genomic sequence analysis for aneuploidy, and a mitochondrial DNA score in euploid embryos, results reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploidy, per embryo tested
0258U	SourceAtomCluster	0258U	False	False	CPT	5	0					NONE	NONE		NONE	C5691519;C5698214;C5696593		Autoimmune (psoriasis), mRNA, next-generation sequencing, gene expression profiling of 50-100 genes, skin-surface collection using adhesive patch, algorithm reported as likelihood of response to psoriasis biologics
0260U	SourceAtomCluster	0260U	False	False	CPT	5	0					NONE	NONE		NONE	C5698216;C5970180;C5696595		Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping
0262U	SourceAtomCluster	0262U	False	False	CPT	5	0					NONE	NONE		NONE	C5696597;C5691522;C5698218		Oncology (solid tumor), gene expression profiling by real-time RT-PCR of 7 gene pathways (ER, AR, PI3K, MAPK, HH, TGFB, Notch), formalin-fixed paraffin-embedded (FFPE), algorithm reported as gene pathway activity score
0264U	SourceAtomCluster	0264U	False	False	CPT	5	0					NONE	NONE		NONE	C5671325;C5696595;C5698220		Rare diseases (constitutional/heritable disorders), identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping
0265U	SourceAtomCluster	0265U	False	False	CPT	9	0					NONE	NONE		NONE	C5691524;C5696599;C5698221;C5698225;C5698222;C5698223;C5698224		Rare constitutional and other heritable disorders, whole genome and mitochondrial DNA sequence analysis, blood, frozen and formalin-fixed paraffin-embedded (FFPE) tissue, saliva, buccal swabs or cell lines, identification of single nucleotide and copy number variants
0266U	SourceAtomCluster	0266U	False	False	CPT	7	0					NONE	NONE		NONE	C5696600;C5698227;C5691525;C5698226;C5698228		Unexplained constitutional or other heritable disorders or syndromes, tissue-specific gene expression by whole-transcriptome and next-generation sequencing, blood, formalin-fixed paraffin-embedded (FFPE) tissue or fresh frozen tissue, reported as presence or absence of splicing or expression changes
0267U	SourceAtomCluster	0267U	False	False	CPT	5	0					NONE	NONE		NONE	C5698229;C5691526;C5696601		Rare constitutional and other heritable disorders, identification of copy number variations, inversions, insertions, translocations, and other structural variants by optical genome mapping and whole genome sequencing
0268U	SourceAtomCluster	0268U	False	False	CPT	7	0					NONE	NONE		NONE	C5691527;C5696602;C5698232;C5698230;C5698231		Hematology (atypical hemolytic uremic syndrome [aHUS]), genomic sequence analysis of 15 genes, blood, buccal swab, or amniotic fluid
0269U	SourceAtomCluster	0269U	False	False	CPT	7	0					NONE	NONE		NONE	C5851837;C5691528;C5851834;C5851835;C5851836		Hematology (autosomal dominant congenital thrombocytopenia), genomic sequence analysis of 22 genes, blood, buccal swab, or amniotic fluid
0270U	SourceAtomCluster	0270U	False	False	CPT	7	0					NONE	NONE		NONE	C5691529;C5698237;C5698238;C5698236;C5696604		Hematology (congenital coagulation disorders), genomic sequence analysis of 20 genes, blood, buccal swab, or amniotic fluid
0271U	SourceAtomCluster	0271U	False	False	CPT	7	0					NONE	NONE		NONE	C5851839;C5851841;C5691530;C5851840;C5851838		Hematology (congenital neutropenia), genomic sequence analysis of 24 genes, blood, buccal swab, or amniotic fluid
0272U	SourceAtomCluster	0272U	False	False	CPT	20	0					NONE	NONE		NONE	C5851844;C5851849;C5851855;C5851846;C5851847;C5851848;C5851853;C5691531;C5851842;C5851843;C5851850;C5851852;C5851854;C5851856;C5851845;C5851851;C5851857		Hematology (genetic bleeding disorders), genomic sequence analysis of 60 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid, comprehensive
0273U	SourceAtomCluster	0273U	False	False	CPT	7	0					NONE	NONE		NONE	C5691532;C5698247;C5698245;C5698246		Hematology (genetic hyperfibrinolysis, delayed bleeding), analysis of 9 genes (F13A1, F13B, FGA, FGB, FGG, SERPINA1, SERPINE1, SERPINF2 by next-generation sequencing, and PLAU by array comparative genomic hybridization), blood, buccal swab, or amniotic fluid
0274U	SourceAtomCluster	0274U	False	False	CPT	20	0					NONE	NONE		NONE	C5851859;C5851868;C5851871;C5851872;C5851870;C5691533;C5851858;C5851864;C5851873;C5851860;C5851862;C5851866;C5851867;C5851874;C5851861;C5851863;C5851865;C5851869		Hematology (genetic platelet disorders), genomic sequence analysis of 62 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid
0276U	SourceAtomCluster	0276U	False	False	CPT	7	0					NONE	NONE		NONE	C5702112;C5691535;C5702110;C5702109;C5702111		Hematology (inherited thrombocytopenia), genomic sequence analysis of 42 genes, blood, buccal swab, or amniotic fluid
0277U	SourceAtomCluster	0277U	False	False	CPT	31	0					NONE	NONE		NONE	C5851884;C5851893;C5851894;C5851897;C5851885;C5851888;C5851889;C5851891;C5851892;C5691536;C5851878;C5851881;C5851883;C5851886;C5851887;C5851895;C5851896;C5851898;C5851876;C5851877;C5851890;C5851899;C5698257;C5851875;C5851879		Hematology (genetic platelet function disorder), genomic sequence analysis of 40 genes and duplication/deletion of PLAU, blood, buccal swab, or amniotic fluid
0278U	SourceAtomCluster	0278U	False	False	CPT	8	0					NONE	NONE		NONE	C5851902;C5851904;C5851901;C5691537;C5851903		Hematology (genetic thrombosis), genomic sequence analysis of 14 genes, blood, buccal swab, or amniotic fluid
0282U	SourceAtomCluster	0282U	False	False	CPT	5	0					NONE	NONE		NONE	C5691541;C5698264;C5696616		Red blood cell antigen typing, DNA, genotyping of 12 blood group system genes to predict 44 red blood cell antigen phenotypes
0285U	SourceAtomCluster	0285U	False	False	CPT	5	0					NONE	NONE		NONE	C5702113;C5702114		Oncology, response to radiation, cell-free DNA, quantitative branched chain DNA amplification, plasma, reported as a radiation toxicity score
0286U	SourceAtomCluster	0286U	False	False	CPT	5	0					NONE	NONE		NONE	C5702115		CEP72 (centrosomal protein, 72-KDa), NUDT15 (nudix hydrolase 15) and TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants
0287U	SourceAtomCluster	0287U	False	False	CPT	6	0					NONE	NONE		NONE	C5702117;C5702119;C5702116;C5702118		Oncology (thyroid), DNA and mRNA, next-generation sequencing analysis of 112 genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithmic prediction of cancer recurrence, reported as a categorical risk result (low, intermediate, high)
0288U	SourceAtomCluster	0288U	False	False	CPT	5	0					NONE	NONE		NONE	C5702120;C5702121		Oncology (lung), mRNA, quantitative PCR analysis of 11 genes (BAG1, BRCA1, CDC6, CDK2AP1, ERBB3, FUT3, IL11, LCK, RND3, SH3BGR, WNT3A) and 3 reference genes (ESD, TBP, YAP1), formalin-fixed paraffin-embedded (FFPE) tumor tissue, algorithmic interpretation reported as a recurrence risk score
0289U	SourceAtomCluster	0289U	False	False	CPT	5	0					NONE	NONE		NONE	C5702122		Neurology (Alzheimer disease), mRNA, gene expression profiling by RNA sequencing of 24 genes, whole blood, algorithm reported as predictive risk score
0290U	SourceAtomCluster	0290U	False	False	CPT	5	0					NONE	NONE		NONE	C5702123		Pain management, mRNA, gene expression profiling by RNA sequencing of 36 genes, whole blood, algorithm reported as predictive risk score
0291U	SourceAtomCluster	0291U	False	False	CPT	5	0					NONE	NONE		NONE	C5702124		Psychiatry (mood disorders), mRNA, gene expression profiling by RNA sequencing of 144 genes, whole blood, algorithm reported as predictive risk score
0292U	SourceAtomCluster	0292U	False	False	CPT	5	0					NONE	NONE		NONE	C5702125		Psychiatry (stress disorders), mRNA, gene expression profiling by RNA sequencing of 72 genes, whole blood, algorithm reported as predictive risk score
0293U	SourceAtomCluster	0293U	False	False	CPT	5	0					NONE	NONE		NONE	C5702126		Psychiatry (suicidal ideation), mRNA, gene expression profiling by RNA sequencing of 54 genes, whole blood, algorithm reported as predictive risk score
0294U	SourceAtomCluster	0294U	False	False	CPT	5	0					NONE	NONE		NONE	C5702127;C5702128		Longevity and mortality risk, mRNA, gene expression profiling by RNA sequencing of 18 genes, whole blood, algorithm reported as predictive risk score
0296U	SourceAtomCluster	0296U	False	False	CPT	5	0					NONE	NONE		NONE	C5702131;C5702132		Oncology (oral and/or oropharyngeal cancer), gene expression profiling by RNA sequencing of at least 20 molecular features (eg, human and/or microbial mRNA), saliva, algorithm reported as positive or negative for signature associated with malignancy
0297U	SourceAtomCluster	0297U	False	False	CPT	8	0					NONE	NONE		NONE	C5702135;C5702137;C5702133;C5702134;C5702138;C5702136		Oncology (pan tumor), whole genome sequencing of paired malignant and normal DNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and variant identification
0298U	SourceAtomCluster	0298U	False	False	CPT	8	0					NONE	NONE		NONE	C5702139;C5702144;C5702143;C5702140;C5702141;C5702142		Oncology (pan tumor), whole transcriptome sequencing of paired malignant and normal RNA specimens, fresh or formalin-fixed paraffin-embedded (FFPE) tissue, blood or bone marrow, comparative sequence analyses and expression level and chimeric transcript identification
0299U	SourceAtomCluster	0299U	False	False	CPT	7	0					NONE	NONE		NONE	C5702148;C5702146;C5702145;C5702147;C5702149		Oncology (pan tumor), whole genome optical genome mapping of paired malignant and normal DNA specimens, fresh frozen tissue, blood, or bone marrow, comparative structural variant identification
0300U	SourceAtomCluster	0300U	False	False	CPT	7	0					NONE	NONE		NONE	C5702152;C5702150;C5702153;C5702151		Oncology (pan tumor), whole genome sequencing and optical genome mapping of paired malignant and normal DNA specimens, fresh tissue, blood, or bone marrow, comparative sequence analyses and variant identification
0301U	SourceAtomCluster	0301U	False	False	CPT	5	0					NONE	NONE		NONE	C5702154;C5702155		Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR)
0302U	SourceAtomCluster	0302U	False	False	CPT	5	0					NONE	NONE		NONE	C5702156;C5702157		Infectious agent detection by nucleic acid (DNA or RNA), Bartonella henselae and Bartonella quintana, droplet digital PCR (ddPCR); following liquid enrichment
0306U	SourceAtomCluster	0306U	False	False	CPT	5	0					NONE	NONE		NONE	C5702166		Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis, cell-free DNA, initial (baseline) assessment to determine a patient-specific panel for future comparisons to evaluate for MRD
0307U	SourceAtomCluster	0307U	False	False	CPT	5	0					NONE	NONE		NONE	C5702167		Oncology (minimal residual disease [MRD]), next-generation targeted sequencing analysis of a patient-specific panel, cell-free DNA, subsequent assessment with comparison to previously analyzed patient specimens to evaluate for MRD
0313U	SourceAtomCluster	0313U	False	False	CPT	5	0					NONE	NONE		NONE	C5702176		Oncology (pancreas), DNA and mRNA next-generation sequencing analysis of 74 genes and analysis of CEA (CEACAM5) gene expression, pancreatic cyst fluid, algorithm reported as a categorical result (ie, negative, low probability of neoplasia or positive, high probability of neoplasia)
0314U	SourceAtomCluster	0314U	False	False	CPT	5	0					NONE	NONE		NONE	C5702177;C5702178		Oncology (cutaneous melanoma), mRNA gene expression profiling by RT-PCR of 35 genes (32 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical result (ie, benign, intermediate, malignant)
0315U	SourceAtomCluster	0315U	False	False	CPT	5	0					NONE	NONE		NONE	C5702179		Oncology (cutaneous squamous cell carcinoma), mRNA gene expression profiling by RT-PCR of 40 genes (34 content and 6 housekeeping), utilizing formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as a categorical risk result (ie, Class 1, Class 2A, Class 2B)
0317U	SourceAtomCluster	0317U	False	False	CPT	5	0					NONE	NONE		NONE	C5702181		Oncology (lung cancer), four-probe FISH (3q29, 3p22.1, 10q22.3, 10cen) assay, whole blood, predictive algorithm-generated evaluation reported as decreased or increased risk for lung cancer
0317U	SourceAtomCluster	0317U	False	False	CPT	5	0					NONE	NONE		NONE	C5702181		Oncology (lung cancer), four-probe FISH (3q29, 3p22.1, 10q22.3, 10cen) assay, whole blood, predictive algorithm-generated evaluation reported as decreased or increased risk for lung cancer
0326U	SourceAtomCluster	0326U	False	False	CPT	5	0					NONE	NONE		NONE	C5702196;C5702197		Targeted genomic sequence analysis panel, solid organ neoplasm, cell-free circulating DNA analysis of 83 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden
0329U	SourceAtomCluster	0329U	False	False	CPT	6	0					NONE	NONE		NONE	C5702205;C5702206;C5702203;C5702204		Oncology (neoplasia), exome and transcriptome sequence analysis for sequence variants, gene copy number amplifications and deletions, gene rearrangements, microsatellite instability and tumor mutational burden utilizing DNA and RNA from tumor with DNA from normal blood or saliva for subtraction, report of clinically significant mutation(s) with therapy associations
0331U	SourceAtomCluster	0331U	False	False	CPT	6	0					NONE	NONE		NONE	C5702209;C5702210;C5702212;C5702211		Oncology (hematolymphoid neoplasia), optical genome mapping for copy number alterations and gene rearrangements utilizing DNA from blood or bone marrow, report of clinically significant alterations
0332U	SourceAtomCluster	0332U	False	False	CPT	5	0					NONE	NONE		NONE	C5702214;C5702213		Oncology (pan-tumor), genetic profiling of 8 DNA-regulatory (epigenetic) markers by quantitative polymerase chain reaction (qPCR), whole blood, reported as a high or low probability of responding to immune checkpoint-inhibitor therapy
0333U	SourceAtomCluster	0333U	False	False	CPT	5	0					NONE	NONE		NONE	C5702215;C5702216		Oncology (liver), surveillance for hepatocellular carcinoma (HCC) in high-risk patients, analysis of methylation patterns on circulating cell-free DNA (cfDNA) plus measurement of serum of AFP/AFP-L3 and oncoprotein des-gamma-carboxy-prothrombin (DCP), algorithm reported as normal or abnormal result
0334U	SourceAtomCluster	0334U	False	False	CPT	5	0					NONE	NONE		NONE	C5702217;C5702218		Oncology (solid organ), targeted genomic sequence analysis, formalin-fixed paraffin-embedded (FFPE) tumor tissue, DNA analysis, 84 or more genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden
0335U	SourceAtomCluster	0335U	False	False	CPT	5	0					NONE	NONE		NONE	C5702219		Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, fetal sample, identification and categorization of genetic variants
0336U	SourceAtomCluster	0336U	False	False	CPT	8	0					NONE	NONE		NONE	C5702221;C5702225;C5702220;C5702222;C5702224;C5702223		Rare diseases (constitutional/heritable disorders), whole genome sequence analysis, including small sequence changes, copy number variants, deletions, duplications, mobile element insertions, uniparental disomy (UPD), inversions, aneuploidy, mitochondrial genome sequence analysis with heteroplasmy and large deletions, short tandem repeat (STR) gene expansions, blood or saliva, identification and categorization of genetic variants, each comparator genome (eg, parent)
0339U	SourceAtomCluster	0339U	False	False	CPT	5	0					NONE	NONE		NONE	C5702231;C5702230		Oncology (prostate), mRNA expression profiling of HOXC6 and DLX1, reverse transcription polymerase chain reaction (RT-PCR), first-void urine following digital rectal examination, algorithm reported as probability of high-grade cancer
0340U	SourceAtomCluster	0340U	False	False	CPT	6	0					NONE	NONE		NONE	C5702232;C5702233;C5702234		Oncology (pan-cancer), analysis of minimal residual disease (MRD) from plasma, with assays personalized to each patient based on prior next-generation sequencing of the patient's tumor and germline DNA, reported as absence or presence of MRD, with disease-burden correlation, if appropriate
0341U	SourceAtomCluster	0341U	False	False	CPT	5	0					NONE	NONE		NONE	C5702236;C5702235		Fetal aneuploidy DNA sequencing comparative analysis, fetal DNA from products of conception, reported as normal (euploidy), monosomy, trisomy, or partial deletion/duplication, mosaicism, and segmental aneuploid
0343U	SourceAtomCluster	0343U	False	False	CPT	5	0					NONE	NONE		NONE	C5702239;C5702240		Oncology (prostate), exosome-based analysis of 442 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as molecular evidence of no-, low-, intermediate- or high-risk of prostate cancer
0345U	SourceAtomCluster	0345U	False	False	CPT	5	0					NONE	NONE		NONE	C5702243;C5702245;C5702244		Psychiatry (eg, depression, anxiety, attention deficit hyperactivity disorder [ADHD]), genomic analysis panel, variant analysis of 15 genes, including deletion/duplication analysis of CYP2D6
0355U	SourceAtomCluster	0355U	False	False	CPT	6	0					NONE	NONE		NONE	C5702960		APOL1 (apolipoprotein L1) (eg, chronic kidney disease), risk variants (G1, G2)
0356U	SourceAtomCluster	0356U	False	False	CPT	5	0					NONE	NONE		NONE	C5944588;C5944589;C5771752		Oncology (oropharyngeal or anal), evaluation of 17 DNA biomarkers using droplet digital PCR (ddPCR), cell-free DNA, algorithm reported as a prognostic risk score for cancer recurrence
0362U	SourceAtomCluster	0362U	False	False	CPT	7	0					NONE	NONE		NONE	C5851911;C5851910;C5771758;C5851912		Oncology (papillary thyroid cancer), gene-expression profiling via targeted hybrid capture-enrichment RNA sequencing of 82 content genes and 10 housekeeping genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as one of three molecular subtypes
0363U	SourceAtomCluster	0363U	False	False	CPT	5	0					NONE	NONE		NONE	C5851913;C5771759		Oncology (urothelial), mRNA, gene-expression profiling by real-time quantitative PCR of 5 genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm incorporates age, sex, smoking history, and macrohematuria frequency, reported as a risk score for having urothelial carcinoma
0364U	SourceAtomCluster	0364U	False	False	CPT	5	0					NONE	NONE		NONE	C5851914;C5851915;C5851916		Oncology (hematolymphoid neoplasm), genomic sequence analysis using multiplex (PCR) and next-generation sequencing with algorithm, quantification of dominant clonal sequence(s), reported as presence or absence of minimal residual disease (MRD) with quantitation of disease burden, when appropriate
0368U	SourceAtomCluster	0368U	False	False	CPT	7	0					NONE	NONE		NONE	C5851926;C5851929;C5851927;C5851928		Oncology (colorectal cancer), evaluation for mutations of APC, BRAF, CTNNB1, KRAS, NRAS, PIK3CA, SMAD4, and TP53, and methylation markers (MYO1G, KCNQ5, C9ORF50, FLI1, CLIP4, ZNF132, and TWIST1), multiplex quantitative polymerase chain reaction (qPCR), circulating cell-free DNA (cfDNA), plasma, report of risk score for advanced adenoma or colorectal cancer
0369U	SourceAtomCluster	0369U	False	False	CPT	7	0					NONE	NONE		NONE	C5851931;C5851930;C5851934;C5851932;C5851933		Infectious agent detection by nucleic acid (DNA and RNA), gastrointestinal pathogens, 31 bacterial, viral, and parasitic organisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique
0370U	SourceAtomCluster	0370U	False	False	CPT	7	0					NONE	NONE		NONE	C5851939;C5851935;C5851938;C5851937;C5851936		Infectious agent detection by nucleic acid (DNA and RNA), surgical wound pathogens, 34 microorganisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique, wound swab
0371U	SourceAtomCluster	0371U	False	False	CPT	7	0					NONE	NONE		NONE	C5851940;C5851944;C5851941;C5851942;C5851943		Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogen, semiquantitative identification, DNA from 16 bacterial organisms and 1 fungal organism, multiplex amplified probe technique via quantitative polymerase chain reaction (qPCR), urine
0372U	SourceAtomCluster	0372U	False	False	CPT	5	0					NONE	NONE		NONE	C5851945;C5851946		Infectious disease (genitourinary pathogens), antibiotic-resistance gene detection, multiplex amplified probe technique, urine, reported as an antimicrobial stewardship risk score
0373U	SourceAtomCluster	0373U	False	False	CPT	13	0					NONE	NONE		NONE	C5851947;C5851950;C5851948;C5851953;C5851949;C5851956;C5851951;C5851954;C5851955;C5851952		Infectious agent detection by nucleic acid (DNA and RNA), respiratory tract infection, 17 bacteria, 8 fungus, 13 virus, and 16 antibiotic-resistance genes, multiplex amplified probe technique, upper or lower respiratory specimen
0374U	SourceAtomCluster	0374U	False	False	CPT	7	0					NONE	NONE		NONE	C5851957;C5851960;C5851958;C5851959		Infectious agent detection by nucleic acid (DNA or RNA), genitourinary pathogens, identification of 21 bacterial and fungal organisms and identification of 21 associated antibiotic-resistance genes, multiplex amplified probe technique, urine
0378U	SourceAtomCluster	0378U	False	False	CPT	8	0					NONE	NONE		NONE	C5851968;C5851970;C5851969;C5851972;C5851971		RFC1 (replication factor C subunit 1), repeat expansion variant analysis by traditional and repeat-primed PCR, blood, saliva, or buccal swab
0379U	SourceAtomCluster	0379U	False	False	CPT	5	0					NONE	NONE		NONE	C5851973;C5851974		Targeted genomic sequence analysis panel, solid organ neoplasm, DNA (523 genes) and RNA (55 genes) by next-generation sequencing, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutational burden
0380U	SourceAtomCluster	0380U	False	False	CPT	7	0					NONE	NONE		NONE	C5851976;C5851978;C5851977;C5851975		Drug metabolism (adverse drug reactions and drug response), targeted sequence analysis, 20 gene variants and CYP2D6 deletion or duplication analysis with reported genotype and phenotype
0388U	SourceAtomCluster	0388U	False	False	CPT	5	0					NONE	NONE		NONE	C5851991;C5851992		Oncology (non-small cell lung cancer), next-generation sequencing with identification of single nucleotide variants, copy number variants, insertions and deletions, and structural variants in 37 cancer-related genes, plasma, with report for alteration detection
0389U	SourceAtomCluster	0389U	False	False	CPT	5	0					NONE	NONE		NONE	C5851993;C5851994		Pediatric febrile illness (Kawasaki disease [KD]), interferon alpha-inducible protein 27 (IFI27) and mast cell-expressed membrane protein 1 (MCEMP1), RNA, using quantitative reverse transcription polymerase chain reaction (RT-qPCR), blood, reported as a risk score for KD
0391U	SourceAtomCluster	0391U	False	False	CPT	5	0					NONE	NONE		NONE	C5851997;C5851998		Oncology (solid tumor), DNA and RNA by next-generation sequencing, utilizing formalin-fixed paraffin-embedded (FFPE) tissue, 437 genes, interpretive report for single nucleotide variants, splice-site variants, insertions/deletions, copy number alterations, gene fusions, tumor mutational burden, and microsatellite instability, with algorithm quantifying immunotherapy response score
0392U	SourceAtomCluster	0392U	False	False	CPT	16	0					NONE	NONE		NONE	C5851999;C5852003;C5852004;C5852007;C5852011;C5852000;C5852001;C5852002;C5852006;C5852008;C5852009;C5852005;C5852010		Drug metabolism (depression, anxiety, attention deficit hyperactivity disorder [ADHD]), gene-drug interactions, variant analysis of 16 genes, including deletion/duplication analysis of CYP2D6, reported as impact of gene-drug interaction for each drug
0396U																		
0398U	SourceAtomCluster	0398U	False	False	CPT	5	0					NONE	NONE		NONE	C5852031;C5852030		Gastroenterology (Barrett's esophagus), P16, RUNX3, HPP1, and FBN1 DNA methylation analysis using PCR, formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as risk score for progression to high-grade dysplasia or cancer
0400U	SourceAtomCluster	0400U	False	False	CPT	5	0					NONE	NONE		NONE	C5852035;C5852036		Obstetrics (expanded carrier screening), 145 genes by next-generation sequencing, fragment analysis and multiplex ligation-dependent probe amplification, DNA, reported as carrier positive or negative
0403U	SourceAtomCluster	0403U	False	False	CPT	5	0					NONE	NONE		NONE	C5852047;C5852048;C5944590		Oncology (prostate), mRNA, gene expression profiling of 18 genes, first-catch urine, algorithm reported as percentage of likelihood of detecting clinically significant prostate cancer
0405U	SourceAtomCluster	0405U	False	False	CPT	5	0					NONE	NONE		NONE	C5852053;C5852054		Oncology (pancreatic), 59 methylation haplotype block markers, next-generation sequencing, plasma, reported as cancer signal detected or not detected
0409U	SourceAtomCluster	0409U	False	False	CPT	5	0					NONE	NONE		NONE	C5852060;C5852061		Oncology (solid tumor), DNA (80 genes) and RNA (36 genes), by next-generation sequencing from plasma, including single nucleotide variants, insertions/deletions, copy number alterations, microsatellite instability, and fusions, report showing identified mutations with clinical actionability
0410U	SourceAtomCluster	0410U	False	False	CPT	7	0					NONE	NONE		NONE	C5852062;C5852065;C5852063;C5852064;C5852066		Oncology (pancreatic), DNA, whole genome sequencing with 5-hydroxymethylcytosine enrichment, whole blood or plasma, algorithm reported as cancer detected or not detected
0411U	SourceAtomCluster	0411U	False	False	CPT	8	0					NONE	NONE		NONE	C5852068;C5848697;C5852069;C5852070;C5852071;C5852067		Psychiatry (eg, depression, anxiety, attention deficit hyperactivity disorder [ADHD]), genomic analysis panel, variant analysis of 15 genes, including deletion/duplication analysis of CYP2D6
0413U	SourceAtomCluster	0413U	False	False	CPT	5	0					NONE	NONE		NONE	C5852074;C5852075		Oncology (hematolymphoid neoplasm), optical genome mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements, DNA from blood or bone marrow, report of clinically significant alterations
0417U	SourceAtomCluster	0417U	False	False	CPT	7	0					NONE	NONE		NONE	C5852085;C5852086;C5852087;C5852083;C5852084		Rare diseases (constitutional/heritable disorders), whole mitochondrial genome sequence with heteroplasmy detection and deletion analysis, nuclear-encoded mitochondrial gene analysis of 335 nuclear genes, including sequence changes, deletions, insertions, and copy number variants analysis, blood or saliva, identification and categorization of mitochondrial disorder-associated genetic variants
0419U	SourceAtomCluster	0419U	False	False	CPT	13	0					NONE	NONE		NONE	C5852091;C5852092;C5852101;C5852094;C5852096;C5852099;C5852100;C5852093;C5852095;C5852097;C5852098		Neuropsychiatry (eg, depression, anxiety), genomic sequence analysis panel, variant analysis of 13 genes, saliva or buccal swab, report of each gene phenotype
0392U	SourceAtomCluster	0392U	False	False	CPT	16	0					NONE	NONE		NONE	C5851999;C5852003;C5852004;C5852007;C5852011;C5852000;C5852001;C5852002;C5852006;C5852008;C5852009;C5852005;C5852010		Drug metabolism (depression, anxiety, attention deficit hyperactivity disorder [ADHD]), gene-drug interactions, variant analysis of 16 genes, including deletion/duplication analysis of CYP2D6, reported as impact of gene-drug interaction for each drug
0396U																		
0398U	SourceAtomCluster	0398U	False	False	CPT	5	0					NONE	NONE		NONE	C5852031;C5852030		Gastroenterology (Barrett's esophagus), P16, RUNX3, HPP1, and FBN1 DNA methylation analysis using PCR, formalin-fixed paraffin-embedded (FFPE) tissue, algorithm reported as risk score for progression to high-grade dysplasia or cancer
0400U	SourceAtomCluster	0400U	False	False	CPT	5	0					NONE	NONE		NONE	C5852035;C5852036		Obstetrics (expanded carrier screening), 145 genes by next-generation sequencing, fragment analysis and multiplex ligation-dependent probe amplification, DNA, reported as carrier positive or negative
0403U	SourceAtomCluster	0403U	False	False	CPT	5	0					NONE	NONE		NONE	C5852047;C5852048;C5944590		Oncology (prostate), mRNA, gene expression profiling of 18 genes, first-catch urine, algorithm reported as percentage of likelihood of detecting clinically significant prostate cancer
0405U	SourceAtomCluster	0405U	False	False	CPT	5	0					NONE	NONE		NONE	C5852053;C5852054		Oncology (pancreatic), 59 methylation haplotype block markers, next-generation sequencing, plasma, reported as cancer signal detected or not detected
0409U	SourceAtomCluster	0409U	False	False	CPT	5	0					NONE	NONE		NONE	C5852060;C5852061		Oncology (solid tumor), DNA (80 genes) and RNA (36 genes), by next-generation sequencing from plasma, including single nucleotide variants, insertions/deletions, copy number alterations, microsatellite instability, and fusions, report showing identified mutations with clinical actionability
0410U	SourceAtomCluster	0410U	False	False	CPT	7	0					NONE	NONE		NONE	C5852062;C5852065;C5852063;C5852064;C5852066		Oncology (pancreatic), DNA, whole genome sequencing with 5-hydroxymethylcytosine enrichment, whole blood or plasma, algorithm reported as cancer detected or not detected
0411U	SourceAtomCluster	0411U	False	False	CPT	8	0					NONE	NONE		NONE	C5852068;C5848697;C5852069;C5852070;C5852071;C5852067		Psychiatry (eg, depression, anxiety, attention deficit hyperactivity disorder [ADHD]), genomic analysis panel, variant analysis of 15 genes, including deletion/duplication analysis of CYP2D6
0413U	SourceAtomCluster	0413U	False	False	CPT	5	0					NONE	NONE		NONE	C5852074;C5852075		Oncology (hematolymphoid neoplasm), optical genome mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements, DNA from blood or bone marrow, report of clinically significant alterations
0417U	SourceAtomCluster	0417U	False	False	CPT	7	0					NONE	NONE		NONE	C5852085;C5852086;C5852087;C5852083;C5852084		Rare diseases (constitutional/heritable disorders), whole mitochondrial genome sequence with heteroplasmy detection and deletion analysis, nuclear-encoded mitochondrial gene analysis of 335 nuclear genes, including sequence changes, deletions, insertions, and copy number variants analysis, blood or saliva, identification and categorization of mitochondrial disorder-associated genetic variants
0419U	SourceAtomCluster	0419U	False	False	CPT	13	0					NONE	NONE		NONE	C5852091;C5852092;C5852101;C5852094;C5852096;C5852099;C5852100;C5852093;C5852095;C5852097;C5852098		Neuropsychiatry (eg, depression, anxiety), genomic sequence analysis panel, variant analysis of 13 genes, saliva or buccal swab, report of each gene phenotype
0420U	SourceAtomCluster	0420U	False	False	CPT	5	0					NONE	NONE		NONE	C5884297;C5944591		Oncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysis of 6 single-nucleotide polymorphisms (SNPs) of genes TERT and FGFR3, urine, algorithm reported as a risk score for urothelial carcinoma
0423U	SourceAtomCluster	0423U	False	False	CPT	5	0					NONE	NONE		NONE	C5884300;C5944595;C5944596		Psychiatry (eg, depression, anxiety), genomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition
0424U	SourceAtomCluster	0424U	False	False	CPT	5	0					NONE	NONE		NONE	C5884301;C5944597		Oncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as no molecular evidence, low-, moderate-, or elevated-risk of prostate cancer
0433U	SourceAtomCluster	0433U	False	False	CPT	5	0					NONE	NONE		NONE	C5944609;C5884310		Oncology (prostate), 5 DNA regulatory markers by quantitative PCR, whole blood, algorithm, including prostate-specific antigen, reported as likelihood of cancer
0444U	SourceAtomCluster	0444U	False	False	CPT	5	0					NONE	NONE		NONE	C5944627		Oncology (solid organ neoplasia), targeted genomic sequence analysis panel of 361 genes, interrogation for gene fusions, translocations, or other rearrangements, using DNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue, report of clinically significant variant(s)
0456U	SourceAtomCluster	0456U	False	False	CPT	5	0					NONE	NONE		NONE	C5944656;C5944657		Autoimmune (rheumatoid arthritis), next-generation sequencing (NGS), gene expression testing of 19 genes, whole blood, with analysis of anti-cyclic citrullinated peptides (CCP) levels, combined with sex, patient global assessment, and body mass index (BMI), algorithm reported as a score that predicts nonresponse to tumor necrosis factor inhibitor (TNFi) therapy
0457U	SourceAtomCluster	0457U	False	False	CPT	6	0					NONE	NONE		NONE	C5944659;C5944660;C5944658;C5944661		Perfluoroalkyl substances (PFAS) (eg, perfluorooctanoic acid, perfluorooctane sulfonic acid), 9 PFAS compounds by LC-MS/MS, plasma or serum, quantitative
0458U	SourceAtomCluster	0458U	False	False	CPT	5	0					NONE	NONE		NONE	C5944662;C5944663		Oncology (breast cancer), S100A8 and S100A9, by enzyme-linked immunosorbent assay (ELISA), tear fluid with age, algorithm reported as a risk score
0459U	SourceAtomCluster	0459U	False	False	CPT	5	0					NONE	NONE		NONE	C5944664;C5944665		-amyloid (Abeta42) and total tau (tTau), electrochemiluminescent immunoassay (ECLIA), cerebral spinal fluid, ratio reported as positive or negative for amyloid pathology
0460U	SourceAtomCluster	0460U	False	False	CPT	6	0					NONE	NONE		NONE	C5944667;C5944668;C5944666;C5944669		Oncology, whole blood or buccal, DNA single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, with variant analysis and reported phenotypes
0461U	SourceAtomCluster	0461U	False	False	CPT	6	0					NONE	NONE		NONE	C5944670;C5944671;C5944672;C5944673		Oncology, pharmacogenomic analysis of single-nucleotide polymorphism (SNP) genotyping by real-time PCR of 24 genes, whole blood or buccal swab, with variant analysis, including impacted gene-drug interactions and reported phenotypes
0462U	SourceAtomCluster	0462U	False	False	CPT	5	0					NONE	NONE		NONE	C5944674;C5944675		Melatonin levels test, sleep study, 7 or 9 sample melatonin profile (cortisol optional), enzyme-linked immunosorbent assay (ELISA), saliva, screening/preliminary
0463U	SourceAtomCluster	0463U	False	False	CPT	6	0					NONE	NONE		NONE	C5944676;C5944677;C5944678;C5944679		Oncology (cervix), mRNA gene expression profiling of 14 biomarkers (E6 and E7 of the highest-risk human papillomavirus [HPV] types 16, 18, 31, 33, 45, 52, 58), by real-time nucleic acid sequence-based amplification (NASBA), exo- or endocervical epithelial cells, algorithm reported as positive or negative for increased risk of cervical dysplasia or cancer for each biomarker
0464U	SourceAtomCluster	0464U	False	False	CPT	5	0					NONE	NONE		NONE	C5944681;C5944680		Oncology (colorectal) screening, quantitative real-time target and signal amplification, methylated DNA markers, including LASS4, LRRC4 and PPP2R5C, a reference marker ZDHHC1, and a protein marker (fecal hemoglobin), utilizing stool, algorithm reported as a positive or negative result
0465U	SourceAtomCluster	0465U	False	False	CPT	5	0					NONE	NONE		NONE	C5944682;C5944683		Oncology (urothelial carcinoma), DNA, quantitative methylation-specific PCR of 2 genes (ONECUT2, VIM), algorithmic analysis reported as positive or negative
0466U	SourceAtomCluster	0466U	False	False	CPT	5	0					NONE	NONE		NONE	C5944684;C5944686;C5944685		Cardiology (coronary artery disease [CAD]), DNA, genome-wide association studies (564856 single-nucleotide polymorphisms [SNPs], targeted variant genotyping), patient lifestyle and clinical data, buccal swab, algorithm reported as polygenic risk to acquired heart disease
0467U	SourceAtomCluster	0467U	False	False	CPT	5	0					NONE	NONE		NONE	C5944687;C5944688		Oncology (bladder), DNA, next-generation sequencing (NGS) of 60 genes and whole genome aneuploidy, urine, algorithms reported as minimal residual disease (MRD) status positive or negative and quantitative disease burden
0468U	SourceAtomCluster	0468U	False	False	CPT	6	0					NONE	NONE		NONE	C5944690;C5944689;C5944691;C5944692		Hepatology (nonalcoholic steatohepatitis [NASH]), miR-34a-5p, alpha 2-macroglobulin, YKL40, HbA1c, serum and whole blood, algorithm reported as a single score for NASH activity and fibrosis
0469U	SourceAtomCluster	0469U	False	False	CPT	7	0					NONE	NONE		NONE	C5944693;C5944695;C5944697;C5944694;C5944696		Rare diseases (constitutional/heritable disorders), whole genome sequence analysis for chromosomal abnormalities, copy number variants, duplications/deletions, inversions, unbalanced translocations, regions of homozygosity (ROH), inheritance pattern that indicate uniparental disomy (UPD), and aneuploidy, fetal sample (amniotic fluid, chorionic villus sample, or products of conception), identification and categorization of genetic variants, diagnostic report of fetal results based on phenotype with maternal sample and paternal sample, if performed, as comparators and/or maternal cell contamination
0470U	SourceAtomCluster	0470U	False	False	CPT	5	0					NONE	NONE		NONE	C5944699;C5944698		Oncology (oropharyngeal), detection of minimal residual disease by next-generation sequencing (NGS) based quantitative evaluation of 8 DNA targets, cell-free HPV 16 and 18 DNA from plasma
0471U	SourceAtomCluster	0471U	False	False	CPT	5	0					NONE	NONE		NONE	C5944700;C5944701		Oncology (colorectal cancer), qualitative real-time PCR of 35 variants of KRAS and NRAS genes (exons 2, 3, 4), formalin-fixed paraffin-embedded (FFPE), predictive, identification of detected mutations
0472U	SourceAtomCluster	0472U	False	False	CPT	5	0					NONE	NONE		NONE	C5944702;C5944703		Carbonic anhydrase VI (CA VI), parotid specific/secretory protein (PSP) and salivary protein (SP1) IgG, IgM, and IgA antibodies, enzyme-linked immunosorbent assay (ELISA), semiqualitative, blood, reported as predictive evidence of early Sjgren's syndrome
0473U	SourceAtomCluster	0473U	False	False	CPT	5	0					NONE	NONE		NONE	C5944704;C5944705		Oncology (solid tumor), next-generation sequencing (NGS) of DNA from formalin-fixed paraffin-embedded (FFPE) tissue with comparative sequence analysis from a matched normal specimen (blood or saliva), 648 genes, interrogation for sequence variants, insertion and deletion alterations, copy number variants, rearrangements, microsatellite instability, and tumor-mutation burden
0474U	SourceAtomCluster	0474U	False	False	CPT	5	0					NONE	NONE		NONE	C5944706;C5944707;C5944708		Hereditary pan-cancer (eg, hereditary sarcomas, hereditary endocrine tumors, hereditary neuroendocrine tumors, hereditary cutaneous melanoma), genomic sequence analysis panel of 88 genes with 20 duplications/deletions using next-generation sequencing (NGS), Sanger sequencing, blood or saliva, reported as positive or negative for germline variants, each gene
0475U	SourceAtomCluster	0475U	False	False	CPT	5	0					NONE	NONE		NONE	C5944709;C5944711;C5944710		Hereditary prostate cancer-related disorders, genomic sequence analysis panel using next-generation sequencing (NGS), Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), and array comparative genomic hybridization (CGH), evaluation of 23 genes and duplications/deletions when indicated, pathologic mutations reported with a genetic risk score for prostate cancer
0486U	SourceAtomCluster	0486U	False	False	CPT	5	0					NONE	NONE		NONE	C5944748;C5944749;C5944750		Oncology (pan-solid tumor), next-generation sequencing analysis of tumor methylation markers present in cell-free circulating tumor DNA, algorithm reported as quantitative measurement of methylation as a correlate of tumor fraction
0487U	SourceAtomCluster	0487U	False	False	CPT	5	0					NONE	NONE		NONE	C5944752;C5944751		Oncology (solid tumor), cell-free circulating DNA, targeted genomic sequence analysis panel of 84 genes, interrogation for sequence variants, aneuploidy-corrected gene copy number amplifications and losses, gene rearrangements, and microsatellite instability
0488U	SourceAtomCluster	0488U	False	False	CPT	5	0					NONE	NONE		NONE	C5944753;C5944754;C5944755		Obstetrics (fetal antigen noninvasive prenatal test), cell-free DNA sequence analysis for detection of fetal presence or absence of 1 or more of the Rh, C, c, D, E, Duffy (Fya), or Kell (K) antigen in alloimmunized pregnancies, reported as selected antigen(s) detected or not detected
0489U	SourceAtomCluster	0489U	False	False	CPT	5	0					NONE	NONE		NONE	C5944758;C5944756;C5944757		Obstetrics (single-gene noninvasive prenatal test), cell-free DNA sequence analysis of 1 or more targets (eg, CFTR, SMN1, HBB, HBA1, HBA2) to identify paternally inherited pathogenic variants, and relative mutation-dosage analysis based on molecular counts to determine fetal inheritance of maternal mutation, algorithm reported as a fetal risk score for the condition (eg, cystic fibrosis, spinal muscular atrophy, beta hemoglobinopathies [including sickle cell disease], alpha thalassemia)
81105	SourceAtomCluster	81105	False	False	CPT	5	0					NONE	NONE		NONE	C4523447;C4523448;C5412071		Human Platelet Antigen 1 genotyping (HPA-1), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-1a/b (L33P)
81106	SourceAtomCluster	81106	False	False	CPT	5	0					NONE	NONE		NONE	C4523450;C4523451;C5412072		Human Platelet Antigen 2 genotyping (HPA-2), GP1BA (glycoprotein Ib [platelet], alpha polypeptide [GPIba]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-2a/b (T145M)
81107	SourceAtomCluster	81107	False	False	CPT	5	0					NONE	NONE		NONE	C4523454;C4523453;C5412073		Human Platelet Antigen 3 genotyping (HPA-3), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-3a/b (I843S)
81108	SourceAtomCluster	81108	False	False	CPT	5	0					NONE	NONE		NONE	C5412074;C4523456;C4523457		Human Platelet Antigen 4 genotyping (HPA-4), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-4a/b (R143Q)
81109	SourceAtomCluster	81109	False	False	CPT	6	0					NONE	NONE		NONE	C4523459;C4523461;C4523462;C4523460		Human Platelet Antigen 5 genotyping (HPA-5), ITGA2 (integrin, alpha 2 [CD49B, alpha 2 subunit of VLA-2 receptor] [GPIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant (eg, HPA-5a/b [K505E])
81110	SourceAtomCluster	81110	False	False	CPT	5	0					NONE	NONE		NONE	C4523463;C4523465;C4523464		Human Platelet Antigen 6 genotyping (HPA-6w), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa, antigen CD61] [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-6a/b (R489Q)
81111	SourceAtomCluster	81111	False	False	CPT	5	0					NONE	NONE		NONE	C4523466;C4523467;C4523468		Human Platelet Antigen 9 genotyping (HPA-9w), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41] [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-9a/b (V837M)
81112	SourceAtomCluster	81112	False	False	CPT	5	0					NONE	NONE		NONE	C4523469;C4523470;C4523471		Human Platelet Antigen 15 genotyping (HPA-15), CD109 (CD109 molecule) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), gene analysis, common variant, HPA-15a/b (S682Y)
81120	SourceAtomCluster	81120	False	False	CPT	7	0					NONE	NONE		NONE	C4523474;C3708877;C3708878;C4523472;C4523473		IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma), common variants (eg, R132H, R132C)
81121	SourceAtomCluster	81121	False	False	CPT	7	0					NONE	NONE		NONE	C5412075;C4523475;C4523477;C4523479;C4523476		IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma), common variants (eg, R140W, R172M)
81161	SourceAtomCluster	81161	False	False	CPT	5	0					NONE	NONE		NONE	C3702507;C3703919		DMD (dystrophin) (eg, Duchenne/Becker muscular dystrophy) deletion analysis, and duplication analysis, if performed
81162	SourceAtomCluster	81162	False	False	CPT	5	0					NONE	NONE		NONE	C4051862;C5412076;C4732109		BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplication/deletion analysis (ie, detection of large gene rearrangements)
81163	SourceAtomCluster	81163	False	False	CPT	5	0					NONE	NONE		NONE	C4732110;C4732111;C3525598		BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis
81164	SourceAtomCluster	81164	False	False	CPT	5	0					NONE	NONE		NONE	C4732113;C5412077;C4732112		BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)
81165	SourceAtomCluster	81165	False	False	CPT	5	0					NONE	NONE		NONE	C4732117;C4732119;C4732118		BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis
81166	SourceAtomCluster	81166	False	False	CPT	5	0					NONE	NONE		NONE	C4732120;C5412078;C4732121		BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)
81167	SourceAtomCluster	81167	False	False	CPT	5	0					NONE	NONE		NONE	C5412079;C4732124;C4732125		BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)
81168	SourceAtomCluster	81168	False	False	CPT	6	0					NONE	NONE		NONE	C5412083;C5412081;C5412082;C5412080		CCND1/IGH (t(11;14)) (eg, mantle cell lymphoma) translocation analysis, major breakpoint, qualitative and quantitative, if performed
81170	SourceAtomCluster	81170	False	False	CPT	5	0					NONE	NONE		NONE	C4049888;C5412084;C4051968		ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase) (eg, acquired imatinib tyrosine kinase inhibitor resistance), gene analysis, variants in the kinase domain
81171	SourceAtomCluster	81171	False	False	CPT	8	0					NONE	NONE		NONE	C4732129;C4732130;C5850697;C5850698;C5850696		AFF2 (ALF transcription elongation factor 2 [FMR2]) (eg, fragile X intellectual disability 2 [FRAXE]) gene analysis; evaluation to detect abnormal (eg, expanded) alleles
81172	SourceAtomCluster	81172	False	False	CPT	8	0					NONE	NONE		NONE	C4732132;C5850699;C5850701;C4732133;C5850700		AFF2 (ALF transcription elongation factor 2 [FMR2]) (eg, fragile X intellectual disability 2 [FRAXE]) gene analysis; characterization of alleles (eg, expanded size and methylation status)
81173	SourceAtomCluster	81173	False	False	CPT	5	0					NONE	NONE		NONE	C4732136;C4732137;C3708986		AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; full gene sequence
81174	SourceAtomCluster	81174	False	False	CPT	5	0					NONE	NONE		NONE	C4732138;C4732139;C4732140		AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; known familial variant
81175	SourceAtomCluster	81175	False	False	CPT	5	0					NONE	NONE		NONE	C4521524;C4523481;C4523482		ASXL1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; full gene sequence
81176	SourceAtomCluster	81176	False	False	CPT	6	0					NONE	NONE		NONE	C4523484;C4523483;C4523485		ASXL1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia), gene analysis; targeted sequence analysis (eg, exon 12)
81177	SourceAtomCluster	81177	False	False	CPT	5	0					NONE	NONE		NONE	C4732144;C4732145;C4732146		ATN1 (atrophin 1) (eg, dentatorubral-pallidoluysian atrophy) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81178	SourceAtomCluster	81178	False	False	CPT	5	0					NONE	NONE		NONE	C4732147;C4732148;C4732149		ATXN1 (ataxin 1) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81179	SourceAtomCluster	81179	False	False	CPT	5	0					NONE	NONE		NONE	C4732150;C4732151;C4732152		ATXN2 (ataxin 2) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81180	SourceAtomCluster	81180	False	False	CPT	5	0					NONE	NONE		NONE	C4732153;C4732154;C4732155		ATXN3 (ataxin 3) (eg, spinocerebellar ataxia, Machado-Joseph disease) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81181	SourceAtomCluster	81181	False	False	CPT	5	0					NONE	NONE		NONE	C4732156;C4732157;C5412085		ATXN7 (ataxin 7) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81182	SourceAtomCluster	81182	False	False	CPT	5	0					NONE	NONE		NONE	C4732159;C5412086;C4732160		ATXN8OS (ATXN8 opposite strand [non-protein coding]) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81183	SourceAtomCluster	81183	False	False	CPT	5	0					NONE	NONE		NONE	C4732162;C4732164;C4732163		ATXN10 (ataxin 10) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81184	SourceAtomCluster	81184	False	False	CPT	5	0					NONE	NONE		NONE	C4732166;C4732167;C4732168		CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; evaluation to detect abnormal (eg, expanded) alleles
81185	SourceAtomCluster	81185	False	False	CPT	5	0					NONE	NONE		NONE	C4732169;C4732170;C4732171		CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; full gene sequence
81186	SourceAtomCluster	81186	False	False	CPT	5	0					NONE	NONE		NONE	C4732173;C4732172;C4732174		CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; known familial variant
81187	SourceAtomCluster	81187	False	False	CPT	5	0					NONE	NONE		NONE	C4732176;C4732175;C4732177		CNBP (CCHC-type zinc finger nucleic acid binding protein) (eg, myotonic dystrophy type 2) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81188	SourceAtomCluster	81188	False	False	CPT	5	0					NONE	NONE		NONE	C4732180;C4732181;C4732179		CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis; evaluation to detect abnormal (eg, expanded) alleles
81189	SourceAtomCluster	81189	False	False	CPT	5	0					NONE	NONE		NONE	C4732184;C4732182;C4732183		CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis; full gene sequence
81190	SourceAtomCluster	81190	False	False	CPT	5	0					NONE	NONE		NONE	C4732185;C4732186;C4732187		CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis; known familial variant(s)
81191	SourceAtomCluster	81191	False	False	CPT	5	0					NONE	NONE		NONE	C5412087;C5412088;C5412089		NTRK1 (neurotrophic receptor tyrosine kinase 1) (eg, solid tumors) translocation analysis
81192	SourceAtomCluster	81192	False	False	CPT	5	0					NONE	NONE		NONE	C5412090;C5412091;C5412092		NTRK2 (neurotrophic receptor tyrosine kinase 2) (eg, solid tumors) translocation analysis
81193	SourceAtomCluster	81193	False	False	CPT	5	0					NONE	NONE		NONE	C5412094;C5412093;C5412095		NTRK3 (neurotrophic receptor tyrosine kinase 3) (eg, solid tumors) translocation analysis
81194	SourceAtomCluster	81194	False	False	CPT	5	0					NONE	NONE		NONE	C5412096;C5412098;C5412097		NTRK (neurotrophic receptor tyrosine kinase 1, 2, and 3) (eg, solid tumors) translocation analysis
81200	SourceAtomCluster	81200	False	False	CPT	8	0					NONE	NONE		NONE	C3516206;C3248127		ASPA (aspartoacylase) (eg, Canavan disease) gene analysis, common variants (eg, E285A, Y231X)
81201	SourceAtomCluster	81201	False	False	CPT	7	0					NONE	NONE		NONE	C3511542;C3708436;C3708437		APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; full gene sequence
81202	SourceAtomCluster	81202	False	False	CPT	7	0					NONE	NONE		NONE	C3511543;C3708438;C3708439		APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; known familial variants
81203	SourceAtomCluster	81203	False	False	CPT	5	0					NONE	NONE		NONE	C3511544;C3703920		APC (adenomatous polyposis coli) (eg, familial adenomatosis polyposis [FAP], attenuated FAP) gene analysis; duplication/deletion variants
81204	SourceAtomCluster	81204	False	False	CPT	5	0					NONE	NONE		NONE	C4732142;C4732141;C4732143		AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; characterization of alleles (eg, expanded size or methylation status)
81205	SourceAtomCluster	81205	False	False	CPT	9	0					NONE	NONE		NONE	C3248128;C3516207;C3525588;C3708443;C3708442;C3708444		BCKDHB (branched-chain keto acid dehydrogenase E1, beta polypeptide) (eg, maple syrup urine disease) gene analysis, common variants (eg, R183P, G278S, E422X)
81206	SourceAtomCluster	81206	False	False	CPT	6	0					NONE	NONE		NONE	C3248129;C3525589;C3525590;C3516209		BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; major breakpoint, qualitative or quantitative
81207	SourceAtomCluster	81207	False	False	CPT	6	0					NONE	NONE		NONE	C3248130;C3525591;C3525592;C3516208		BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; minor breakpoint, qualitative or quantitative
81208	SourceAtomCluster	81208	False	False	CPT	6	0					NONE	NONE		NONE	C3248131;C3525594;C3525593;C3516210		BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis; other breakpoint, qualitative or quantitative
81209	SourceAtomCluster	81209	False	False	CPT	5	0					NONE	NONE		NONE	C3248132;C3525595		BLM (Bloom syndrome, RecQ helicase-like) (eg, Bloom syndrome) gene analysis, 2281del6ins7 variant
81210	SourceAtomCluster	81210	False	False	CPT	5	0					NONE	NONE		NONE	C3248133;C3516211;C5412099		BRAF (B-Raf proto-oncogene, serine/threonine kinase) (eg, colon cancer, melanoma), gene analysis, V600 variant(s)
81212	SourceAtomCluster	81212	False	False	CPT	8	0					NONE	NONE		NONE	C3248135;C4732115;C3527510;C3525599;C3525600		BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; 185delAG, 5385insC, 6174delT variants
81215	SourceAtomCluster	81215	False	False	CPT	5	0					NONE	NONE		NONE	C3248138		BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variant
81216	SourceAtomCluster	81216	False	False	CPT	5	0					NONE	NONE		NONE	C4732127;C3248139		BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis
81217	SourceAtomCluster	81217	False	False	CPT	5	0					NONE	NONE		NONE	C3248140;C4052092;C3703924		BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variant
81218	SourceAtomCluster	81218	False	False	CPT	5	0					NONE	NONE		NONE	C4051861;C3708858;C4051967		CEBPA (CCAAT/enhancer binding protein [C/EBP], alpha) (eg, acute myeloid leukemia), gene analysis, full gene sequence
81219	SourceAtomCluster	81219	False	False	CPT	5	0					NONE	NONE		NONE	C4051966;C4052091;C4051860		CALR (calreticulin) (eg, myeloproliferative disorders), gene analysis, common variants in exon 9
81220	SourceAtomCluster	81220	False	False	CPT	5	0					NONE	NONE		NONE	C3248141;C3525605;C3516215		CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; common variants (eg, ACMG/ACOG guidelines)
81221	SourceAtomCluster	81221	False	False	CPT	5	0					NONE	NONE		NONE	C3248142		CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; known familial variants
81222	SourceAtomCluster	81222	False	False	CPT	5	0					NONE	NONE		NONE	C5412100;C3703925;C3248143		CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; duplication/deletion variants
81223	SourceAtomCluster	81223	False	False	CPT	5	0					NONE	NONE		NONE	C3248144		CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; full gene sequence
81224	SourceAtomCluster	81224	False	False	CPT	5	0					NONE	NONE		NONE	C3248145		CFTR (cystic fibrosis transmembrane conductance regulator) (eg, cystic fibrosis) gene analysis; intron 8 poly-T analysis (eg, male infertility)
81225	SourceAtomCluster	81225	False	False	CPT	10	0					NONE	NONE		NONE	C3248146		CYP2C19 (cytochrome P450, family 2, subfamily C, polypeptide 19) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *8, *17)
81226	SourceAtomCluster	81226	False	False	CPT	20	0					NONE	NONE		NONE	C3708456;C3708458;C3708459;C3708466;C3708454;C3248147;C3708465;C3703926;C3708455;C3708457;C3708462;C3708464;C3708452;C3708453;C3708460;C3708461;C3708463		CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *5, *6, *9, *10, *17, *19, *29, *35, *41, *1XN, *2XN, *4XN)
81227	SourceAtomCluster	81227	False	False	CPT	9	0					NONE	NONE		NONE	C3248148		CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *5, *6)
81228	SourceAtomCluster	81228	False	False	CPT	5	0					NONE	NONE		NONE	C5697871;C3248149;C3516217		Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of genomic regions for copy number variants, comparative genomic hybridization [CGH] microarray analysis
81229	SourceAtomCluster	81229	False	False	CPT	5	0					NONE	NONE		NONE	C5696514;C5697872;C3248150		Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of genomic regions for copy number and single nucleotide polymorphism (SNP) variants, comparative genomic hybridization (CGH) microarray analysis
81230	SourceAtomCluster	81230	False	False	CPT	7	0					NONE	NONE		NONE	C4523486;C4523488;C4523490;C4523487;C4523489		CYP3A4 (cytochrome P450 family 3 subfamily A member 4) (eg, drug metabolism), gene analysis, common variant(s) (eg, *2, *22)
81231	SourceAtomCluster	81231	False	False	CPT	11	0					NONE	NONE		NONE	C5412104;C5412106;C4523491;C4523494;C4523492;C5412102;C5412103;C5412105;C5412107		CYP3A5 (cytochrome P450 family 3 subfamily A member 5) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3, *4, *5, *6, *7)
81232	SourceAtomCluster	81232	False	False	CPT	9	0					NONE	NONE		NONE	C4523495;C4523497;C4523496;C4523500;C4523498;C4523499		DPYD (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-FU and capecitabine drug metabolism), gene analysis, common variant(s) (eg, *2A, *4, *5, *6)
81233	SourceAtomCluster	81233	False	False	CPT	8	0					NONE	NONE		NONE	C4732189;C5412109;C4732188;C4732190;C5412108;C5412110		BTK (Bruton's tyrosine kinase) (eg, chronic lymphocytic leukemia) gene analysis, common variants (eg, C481S, C481R, C481F)
81234	SourceAtomCluster	81234	False	False	CPT	5	0					NONE	NONE		NONE	C4732192;C4732193;C4732194		DMPK (DM1 protein kinase) (eg, myotonic dystrophy type 1) gene analysis; evaluation to detect abnormal (expanded) alleles
81235	SourceAtomCluster	81235	False	False	CPT	11	0					NONE	NONE		NONE	C3511545;C5412117;C5412111;C5412114;C5412116;C5412112;C5412113;C5412115		EGFR (epidermal growth factor receptor) (eg, non-small cell lung cancer) gene analysis, common variants (eg, exon 19 LREA deletion, L858R, T790M, G719A, G719S, L861Q)
81236	SourceAtomCluster	81236	False	False	CPT	5	0					NONE	NONE		NONE	C4732200;C4732198;C4732199		EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, myelodysplastic syndrome, myeloproliferative neoplasms) gene analysis, full gene sequence
81237	SourceAtomCluster	81237	False	False	CPT	5	0					NONE	NONE		NONE	C4732202;C4732203;C4732201		EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, diffuse large B-cell lymphoma) gene analysis, common variant(s) (eg, codon 646)
81238	SourceAtomCluster	81238	False	False	CPT	5	0					NONE	NONE		NONE	C4523501;C3708990;C4523502		F9 (coagulation factor IX) (eg, hemophilia B), full gene sequence
81239	SourceAtomCluster	81239	False	False	CPT	5	0					NONE	NONE		NONE	C4732195;C4732196;C4732197		DMPK (DM1 protein kinase) (eg, myotonic dystrophy type 1) gene analysis; characterization of alleles (eg, expanded size)
81240	SourceAtomCluster	81240	False	False	CPT	5	0					NONE	NONE		NONE	C3248151;C3516219		F2 (prothrombin, coagulation factor II) (eg, hereditary hypercoagulability) gene analysis, 20210G>A variant
81241	SourceAtomCluster	81241	False	False	CPT	5	0					NONE	NONE		NONE	C3248152;C3516220		F5 (coagulation factor V) (eg, hereditary hypercoagulability) gene analysis, Leiden variant
81242	SourceAtomCluster	81242	False	False	CPT	6	0					NONE	NONE		NONE	C5412118;C3248153;C5412119		FANCC (Fanconi anemia, complementation group C) (eg, Fanconi anemia, type C) gene analysis, common variant (eg, IVS4+4A>T)
81243	SourceAtomCluster	81243	False	False	CPT	12	0					NONE	NONE		NONE	C3248154;C5850704;C5850705;C5850706;C5850708;C5850703;C5850707		FMR1 (fragile X messenger ribonucleoprotein 1) (eg, fragile X syndrome, X-linked intellectual disability [XLID]) gene analysis; evaluation to detect abnormal (eg, expanded) alleles
81244	SourceAtomCluster	81244	False	False	CPT	12	0					NONE	NONE		NONE	C3248155;C5850710;C5850712;C5850711;C5850713;C5850715;C5850709;C5850714		FMR1 (fragile X messenger ribonucleoprotein 1) (eg, fragile X syndrome, X-linked intellectual disability [XLID]) gene analysis; characterization of alleles (eg, expanded size and promoter methylation status)
81245	SourceAtomCluster	81245	False	False	CPT	8	0					NONE	NONE		NONE	C5412123;C5412122;C3516223;C3248156;C5412121;C5412120		FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; internal tandem duplication (ITD) variants (ie, exons 14, 15)
81246	SourceAtomCluster	81246	False	False	CPT	7	0					NONE	NONE		NONE	C3865330;C3865726;C3865727;C3865515;C3865728		FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; tyrosine kinase domain (TKD) variants (eg, D835, I836)
81247	SourceAtomCluster	81247	False	False	CPT	7	0					NONE	NONE		NONE	C4523505;C4523504;C4523506;C4523507;C4523508		G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; common variant(s) (eg, A, A-)
81248	SourceAtomCluster	81248	False	False	CPT	5	0					NONE	NONE		NONE	C4523510;C4523511;C4523509		G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; known familial variant(s)
81249	SourceAtomCluster	81249	False	False	CPT	5	0					NONE	NONE		NONE	C4521526		G6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice), gene analysis; full gene sequence
81250	SourceAtomCluster	81250	False	False	CPT	8	0					NONE	NONE		NONE	C3248157;C3708479;C3708480;C3525615;C3516224		G6PC (glucose-6-phosphatase, catalytic subunit) (eg, Glycogen storage disease, type 1a, von Gierke disease) gene analysis, common variants (eg, R83C, Q347X)
81251	SourceAtomCluster	81251	False	False	CPT	9	0					NONE	NONE		NONE	C3248158;C3516225		GBA (glucosidase, beta, acid) (eg, Gaucher disease) gene analysis, common variants (eg, N370S, 84GG, L444P, IVS2+1G>A)
81252	SourceAtomCluster	81252	False	False	CPT	5	0					NONE	NONE		NONE	C5412124;C3511546;C3516226		GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; full gene sequence
81253	SourceAtomCluster	81253	False	False	CPT	5	0					NONE	NONE		NONE	C3516227;C3511547		GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; known familial variants
81254	SourceAtomCluster	81254	False	False	CPT	8	0					NONE	NONE		NONE	C3511548;C3516228;C3708481;C3708482		GJB6 (gap junction protein, beta 6, 30kDa, connexin 30) (eg, nonsyndromic hearing loss) gene analysis, common variants (eg, 309kb [del(GJB6-D13S1830)] and 232kb [del(GJB6-D13S1854)])
81255	SourceAtomCluster	81255	False	False	CPT	9	0					NONE	NONE		NONE	C3516229;C5412125;C5412126;C3248159;C5412127;C5412128;C5412129		HEXA (hexosaminidase A [alpha polypeptide]) (eg, Tay-Sachs disease) gene analysis, common variants (eg, 1278insTATC, 1421+1G>C, G269S)
81256	SourceAtomCluster	81256	False	False	CPT	8	0					NONE	NONE		NONE	C3516230;C3248160		HFE (hemochromatosis) (eg, hereditary hemochromatosis) gene analysis, common variants (eg, C282Y, H63D)
81257	SourceAtomCluster	81257	False	False	CPT	15	0					NONE	NONE		NONE	C3516231;C3248161;C4523514;C4523516;C3525621;C4523513;C4523515;C3525620		HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; common deletions or variant (eg, Southeast Asian, Thai, Filipino, Mediterranean, alpha3.7, alpha4.2, alpha20.5, Constant Spring)
81258	SourceAtomCluster	81258	False	False	CPT	5	0					NONE	NONE		NONE	C4523517		HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; known familial variant
81259	SourceAtomCluster	81259	False	False	CPT	5	0					NONE	NONE		NONE	C4523518		HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; full gene sequence
81260	SourceAtomCluster	81260	False	False	CPT	8	0					NONE	NONE		NONE	C3248162;C3516232;C4052090		IKBKAP (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) (eg, familial dysautonomia) gene analysis, common variants (eg, 2507+6T>C, R696P)
81261	SourceAtomCluster	81261	False	False	CPT	6	0					NONE	NONE		NONE	C3248163;C3516233		IGH@ (Immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); amplified methodology (eg, polymerase chain reaction)
81262	SourceAtomCluster	81262	False	False	CPT	6	0					NONE	NONE		NONE	C3516234;C3248164		IGH@ (Immunoglobulin heavy chain locus) (eg, leukemias and lymphomas, B-cell), gene rearrangement analysis to detect abnormal clonal population(s); direct probe methodology (eg, Southern blot)
81263	SourceAtomCluster	81263	False	False	CPT	5	0					NONE	NONE		NONE	C3703927;C3248165		IGH@ (Immunoglobulin heavy chain locus) (eg, leukemia and lymphoma, B-cell), variable region somatic mutation analysis
81264	SourceAtomCluster	81264	False	False	CPT	5	0					NONE	NONE		NONE	C3248166;C3516236		IGK@ (Immunoglobulin kappa light chain locus) (eg, leukemia and lymphoma, B-cell), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)
81265	SourceAtomCluster	81265	False	False	CPT	10	0					NONE	NONE		NONE	C5412131;C5412133;C3708485;C3248167;C3708487;C3516237;C5412130;C5412132		Comparative analysis using Short Tandem Repeat (STR) markers; patient and comparative specimen (eg, pre-transplant recipient and donor germline testing, post-transplant non-hematopoietic recipient germline [eg, buccal swab or other germline tissue sample] and donor testing, twin zygosity testing, or maternal cell contamination of fetal cells)
81266	SourceAtomCluster	81266	False	False	CPT	5	0					NONE	NONE		NONE	C5412134;C5412135;C3248168		Comparative analysis using Short Tandem Repeat (STR) markers; each additional specimen (eg, additional cord blood donor, additional fetal samples from different cultures, or additional zygosity in multiple birth pregnancies) (List separately in addition to code for primary procedure)
81267	SourceAtomCluster	81267	False	False	CPT	5	0					NONE	NONE		NONE	C3248169;C3703928;C3525625		Chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; without cell selection
81268	SourceAtomCluster	81268	False	False	CPT	8	0					NONE	NONE		NONE	C5412137;C5412138;C3248170;C3525626;C5412136;C5412139		Chimerism (engraftment) analysis, post transplantation specimen (eg, hematopoietic stem cell), includes comparison to previously performed baseline analyses; with cell selection (eg, CD3, CD33), each cell type
81269	SourceAtomCluster	81269	False	False	CPT	5	0					NONE	NONE		NONE	C3708900		HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; duplication/deletion variants
81270	SourceAtomCluster	81270	False	False	CPT	5	0					NONE	NONE		NONE	C3516241;C3248171		JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant
81271	SourceAtomCluster	81271	False	False	CPT	6	0					NONE	NONE		NONE	C4732206;C4732207;C5412140;C5412141		HTT (huntingtin) (eg, Huntington disease) gene analysis; evaluation to detect abnormal (eg, expanded) alleles
81272	SourceAtomCluster	81272	False	False	CPT	5	0					NONE	NONE		NONE	C4051965;C4051859;C3708965		KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (eg, gastrointestinal stromal tumor [GIST], acute myeloid leukemia, melanoma), gene analysis, targeted sequence analysis (eg, exons 8, 11, 13, 17, 18)
81273	SourceAtomCluster	81273	False	False	CPT	5	0					NONE	NONE		NONE	C4051858;C4052089;C4051964		KIT (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (eg, mastocytosis), gene analysis, D816 variant(s)
81274	SourceAtomCluster	81274	False	False	CPT	5	0					NONE	NONE		NONE	C4732208;C5412142;C4732209		HTT (huntingtin) (eg, Huntington disease) gene analysis; characterization of alleles (eg, expanded size)
81275	SourceAtomCluster	81275	False	False	CPT	7	0					NONE	NONE		NONE	C5412145;C3248172;C3516242;C5412143;C5412144		KRAS (Kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; variants in exon 2 (eg, codons 12 and 13)
81276	SourceAtomCluster	81276	False	False	CPT	5	0					NONE	NONE		NONE	C4051857;C4051963;C5412146		KRAS (Kirsten rat sarcoma viral oncogene homolog) (eg, carcinoma) gene analysis; additional variant(s) (eg, codon 61, codon 146)
81277	SourceAtomCluster	81277	False	False	CPT	5	0					NONE	NONE		NONE	C5201972;C5201971;C5201973		Cytogenomic neoplasia (genome-wide) microarray analysis, interrogation of genomic regions for copy number and loss-of-heterozygosity variants for chromosomal abnormalities
81278	SourceAtomCluster	81278	False	False	CPT	6	0					NONE	NONE		NONE	C5412147;C5412148;C5412149;C5412150		IGH@/BCL2 (t(14;18)) (eg, follicular lymphoma) translocation analysis, major breakpoint region (MBR) and minor cluster region (mcr) breakpoints, qualitative or quantitative
81279	SourceAtomCluster	81279	False	False	CPT	6	0					NONE	NONE		NONE	C5412152;C5412151;C5412154;C5412153		JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis (eg, exons 12 and 13)
81283	SourceAtomCluster	81283	False	False	CPT	5	0					NONE	NONE		NONE	C4522085		IFNL3 (interferon, lambda 3) (eg, drug response), gene analysis, rs12979860 variant
81284	SourceAtomCluster	81284	False	False	CPT	5	0					NONE	NONE		NONE	C4732212;C4732213;C3708670		FXN (frataxin) (eg, Friedreich ataxia) gene analysis; evaluation to detect abnormal (expanded) alleles
81285	SourceAtomCluster	81285	False	False	CPT	5	0					NONE	NONE		NONE	C4732214;C4732215;C4732216		FXN (frataxin) (eg, Friedreich ataxia) gene analysis; characterization of alleles (eg, expanded size)
81286	SourceAtomCluster	81286	False	False	CPT	5	0					NONE	NONE		NONE	C4732218;C3708930;C4732217		FXN (frataxin) (eg, Friedreich ataxia) gene analysis; full gene sequence
81287	SourceAtomCluster	81287	False	False	CPT	5	0					NONE	NONE		NONE	C3702508;C4732222;C4732223		MGMT (O-6-methylguanine-DNA methyltransferase) (eg, glioblastoma multiforme) promoter methylation analysis
81288	SourceAtomCluster	81288	False	False	CPT	5	0					NONE	NONE		NONE	C5412155;C3854170;C5412156		MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; promoter methylation analysis
81289	SourceAtomCluster	81289	False	False	CPT	5	0					NONE	NONE		NONE	C4732220;C4732221;C4732219		FXN (frataxin) (eg, Friedreich ataxia) gene analysis; known familial variant(s)
81290	SourceAtomCluster	81290	False	False	CPT	8	0					NONE	NONE		NONE	C3516243;C3248176		MCOLN1 (mucolipin 1) (eg, Mucolipidosis, type IV) gene analysis, common variants (eg, IVS3-2A>G, del6.4kb)
81291	SourceAtomCluster	81291	False	False	CPT	8	0					NONE	NONE		NONE	C3248177;C3516244		MTHFR (5,10-methylenetetrahydrofolate reductase) (eg, hereditary hypercoagulability) gene analysis, common variants (eg, 677T, 1298C)
81292	SourceAtomCluster	81292	False	False	CPT	5	0					NONE	NONE		NONE	C3248178;C3516245		MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
81293	SourceAtomCluster	81293	False	False	CPT	5	0					NONE	NONE		NONE	C3248179;C3516246		MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants
81294	SourceAtomCluster	81294	False	False	CPT	5	0					NONE	NONE		NONE	C3248180;C3703931		MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
81295	SourceAtomCluster	81295	False	False	CPT	5	0					NONE	NONE		NONE	C3248181;C3516248		MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
81296	SourceAtomCluster	81296	False	False	CPT	5	0					NONE	NONE		NONE	C3248182;C3516249		MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants
81297	SourceAtomCluster	81297	False	False	CPT	5	0					NONE	NONE		NONE	C3248183;C3703932		MSH2 (mutS homolog 2, colon cancer, nonpolyposis type 1) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
81298	SourceAtomCluster	81298	False	False	CPT	5	0					NONE	NONE		NONE	C3516251;C3248184		MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
81299	SourceAtomCluster	81299	False	False	CPT	5	0					NONE	NONE		NONE	C3516252;C3248185		MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants
81300	SourceAtomCluster	81300	False	False	CPT	5	0					NONE	NONE		NONE	C3703933;C3248186		MSH6 (mutS homolog 6 [E. coli]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
81301	SourceAtomCluster	81301	False	False	CPT	12	0					NONE	NONE		NONE	C3248187;C1881824;C3525635;C3525636		Microsatellite instability analysis (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) of markers for mismatch repair deficiency (eg, BAT25, BAT26), includes comparison of neoplastic and normal tissue, if performed
81302	SourceAtomCluster	81302	False	False	CPT	5	0					NONE	NONE		NONE	C3248188;C3516254		MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; full sequence analysis
81303	SourceAtomCluster	81303	False	False	CPT	5	0					NONE	NONE		NONE	C3248189;C3516255		MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; known familial variant
81304	SourceAtomCluster	81304	False	False	CPT	5	0					NONE	NONE		NONE	C3248190;C3703934		MECP2 (methyl CpG binding protein 2) (eg, Rett syndrome) gene analysis; duplication/deletion variants
81305	SourceAtomCluster	81305	False	False	CPT	5	0					NONE	NONE		NONE	C4732224;C4732226;C4732225		MYD88 (myeloid differentiation primary response 88) (eg, Waldenstrom's macroglobulinemia, lymphoplasmacytic leukemia) gene analysis, p.Leu265Pro (L265P) variant
81306	SourceAtomCluster	81306	False	False	CPT	10	0					NONE	NONE		NONE	C4732227;C4732228;C5412161;C4732229;C5412158;C5412157;C5412159;C5412160		NUDT15 (nudix hydrolase 15) (eg, drug metabolism) gene analysis, common variant(s) (eg, *2, *3, *4, *5, *6)
81307	SourceAtomCluster	81307	False	False	CPT	5	0					NONE	NONE		NONE	C5201976;C5201975;C5201977		PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; full gene sequence
81308	SourceAtomCluster	81308	False	False	CPT	5	0					NONE	NONE		NONE	C5201979;C5201980;C5201978		PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; known familial variant
81309	SourceAtomCluster	81309	False	False	CPT	9	0					NONE	NONE		NONE	C5412163;C5201982;C5201981;C5201983;C5412164;C5412162;C5412165		PIK3CA (phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha) (eg, colorectal and breast cancer) gene analysis, targeted sequence analysis (eg, exons 7, 9, 20)
81310	SourceAtomCluster	81310	False	False	CPT	5	0					NONE	NONE		NONE	C3248191;C3516257		NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, exon 12 variants
81311	SourceAtomCluster	81311	False	False	CPT	5	0					NONE	NONE		NONE	C4051856;C4051962;C4052086		NRAS (neuroblastoma RAS viral [v-ras] oncogene homolog) (eg, colorectal carcinoma), gene analysis, variants in exon 2 (eg, codons 12 and 13) and exon 3 (eg, codon 61)
81312	SourceAtomCluster	81312	False	False	CPT	5	0					NONE	NONE		NONE	C4732232;C4732230;C4732231		PABPN1 (poly[A] binding protein nuclear 1) (eg, oculopharyngeal muscular dystrophy) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81313	SourceAtomCluster	81313	False	False	CPT	5	0					NONE	NONE		NONE	C3865329;C3865514;C5412166		PCA3/KLK3 (prostate cancer antigen 3 [non-protein coding]/kallikrein-related peptidase 3 [prostate specific antigen]) ratio (eg, prostate cancer)
81314	SourceAtomCluster	81314	False	False	CPT	5	0					NONE	NONE		NONE	C4050229;C4051961;C5412167		PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) (eg, gastrointestinal stromal tumor [GIST]), gene analysis, targeted sequence analysis (eg, exons 12, 18)
81315	SourceAtomCluster	81315	False	False	CPT	8	0					NONE	NONE		NONE	C3516258;C5412169;C3248192;C5412170;C5412171;C5412168		PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; common breakpoints (eg, intron 3 and intron 6), qualitative or quantitative
81316	SourceAtomCluster	81316	False	False	CPT	12	0					NONE	NONE		NONE	C5412173;C5412174;C5412176;C5412177;C3248193;C3516259;C5412172;C5412178;C5412175;C5412179		PML/RARalpha, (t(15;17)), (promyelocytic leukemia/retinoic acid receptor alpha) (eg, promyelocytic leukemia) translocation analysis; single breakpoint (eg, intron 3, intron 6 or exon 6), qualitative or quantitative
81317	SourceAtomCluster	81317	False	False	CPT	5	0					NONE	NONE		NONE	C3248194;C3525643;C3516260		PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis
81318	SourceAtomCluster	81318	False	False	CPT	5	0					NONE	NONE		NONE	C3516261;C3248195;C5412180		PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; known familial variants
81319	SourceAtomCluster	81319	False	False	CPT	5	0					NONE	NONE		NONE	C3248196;C5412181;C3703935		PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non-polyposis colorectal cancer, Lynch syndrome) gene analysis; duplication/deletion variants
81320	SourceAtomCluster	81320	False	False	CPT	5	0					NONE	NONE		NONE	C4732235;C4732234;C4732233		PLCG2 (phospholipase C gamma 2) (eg, chronic lymphocytic leukemia) gene analysis, common variants (eg, R665W, S707F, L845F)
81321	SourceAtomCluster	81321	False	False	CPT	5	0					NONE	NONE		NONE	C3511549;C3516263		PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; full sequence analysis
81322	SourceAtomCluster	81322	False	False	CPT	5	0					NONE	NONE		NONE	C3511550;C3516264		PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; known familial variant
81323	SourceAtomCluster	81323	False	False	CPT	5	0					NONE	NONE		NONE	C3703936;C5412182;C3511551		PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; duplication/deletion variant
81324	SourceAtomCluster	81324	False	False	CPT	5	0					NONE	NONE		NONE	C3511552;C5412183;C3703937		PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; duplication/deletion analysis
81325	SourceAtomCluster	81325	False	False	CPT	5	0					NONE	NONE		NONE	C3511553;C3516267		PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; full sequence analysis
81326	SourceAtomCluster	81326	False	False	CPT	5	0					NONE	NONE		NONE	C3511554;C3516268		PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; known familial variant
81327	SourceAtomCluster	81327	False	False	CPT	5	0					NONE	NONE		NONE	C4732236;C4291782;C4732237		SEPT9 (Septin9) (eg, colorectal cancer) promoter methylation analysis
81328	SourceAtomCluster	81328	False	False	CPT	6	0					NONE	NONE		NONE	C4523520;C4523519;C4523521		SLCO1B1 (solute carrier organic anion transporter family, member 1B1) (eg, adverse drug reaction), gene analysis, common variant(s) (eg, *5)
81329	SourceAtomCluster	81329	False	False	CPT	6	0					NONE	NONE		NONE	C4732240;C4732242;C4732241;C4732239		SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; dosage/deletion analysis (eg, carrier testing), includes SMN2 (survival of motor neuron 2, centromeric) analysis, if performed
81330	SourceAtomCluster	81330	False	False	CPT	9	0					NONE	NONE		NONE	C3516269;C3248197;C3525653		SMPD1 (sphingomyelin phosphodiesterase 1, acid lysosomal) (eg, Niemann-Pick disease, Type A) gene analysis, common variants (eg, R496L, L302P, fsP330)
81331	SourceAtomCluster	81331	False	False	CPT	5	0					NONE	NONE		NONE	C5412184;C3248198;C3516270		SNRPN/UBE3A (small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A) (eg, Prader-Willi syndrome and/or Angelman syndrome), methylation analysis
81332	SourceAtomCluster	81332	False	False	CPT	8	0					NONE	NONE		NONE	C3525655;C3248199;C3516271		SERPINA1 (serpin peptidase inhibitor, clade A, alpha-1 antiproteinase, antitrypsin, member 1) (eg, alpha-1-antitrypsin deficiency), gene analysis, common variants (eg, *S and *Z)
81333	SourceAtomCluster	81333	False	False	CPT	5	0					NONE	NONE		NONE	C4732248;C4732250;C4732249		TGFBI (transforming growth factor beta-induced) (eg, corneal dystrophy) gene analysis, common variants (eg, R124H, R124C, R124L, R555W, R555Q)
81334	SourceAtomCluster	81334	False	False	CPT	6	0					NONE	NONE		NONE	C4523522;C4523523		RUNX1 (runt related transcription factor 1) (eg, acute myeloid leukemia, familial platelet disorder with associated myeloid malignancy) gene analysis, targeted sequence analysis (eg, exons 3-8)
81335	SourceAtomCluster	81335	False	False	CPT	6	0					NONE	NONE		NONE	C3708795;C3708792		TPMT (thiopurine S-methyltransferase) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3)
81336	SourceAtomCluster	81336	False	False	CPT	5	0					NONE	NONE		NONE	C4732244;C4732243;C3709038		SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; full gene sequence
81337	SourceAtomCluster	81337	False	False	CPT	5	0					NONE	NONE		NONE	C4732245;C4732246;C4732247		SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; known familial sequence variant(s)
81338	SourceAtomCluster	81338	False	False	CPT	6	0					NONE	NONE		NONE	C5412188;C5412186;C5412187;C5412189		MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; common variants (eg, W515A, W515K, W515L, W515R)
81339	SourceAtomCluster	81339	False	False	CPT	5	0					NONE	NONE		NONE	C5412190;C5412192;C5412191		MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; sequence analysis, exon 10
81340	SourceAtomCluster	81340	False	False	CPT	6	0					NONE	NONE		NONE	C3516272;C5412193;C3248200;C5412194		TRB@ (T cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using amplification methodology (eg, polymerase chain reaction)
81341	SourceAtomCluster	81341	False	False	CPT	6	0					NONE	NONE		NONE	C3248201;C5412195;C5412196		TRB@ (T cell antigen receptor, beta) (eg, leukemia and lymphoma), gene rearrangement analysis to detect abnormal clonal population(s); using direct probe methodology (eg, Southern blot)
81342	SourceAtomCluster	81342	False	False	CPT	5	0					NONE	NONE		NONE	C3248202		TRG@ (T cell antigen receptor, gamma) (eg, leukemia and lymphoma), gene rearrangement analysis, evaluation to detect abnormal clonal population(s)
81343	SourceAtomCluster	81343	False	False	CPT	5	0					NONE	NONE		NONE	C4732252;C4732251;C4732253		PPP2R2B (protein phosphatase 2 regulatory subunit Bbeta) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81344	SourceAtomCluster	81344	False	False	CPT	5	0					NONE	NONE		NONE	C4732254;C4732256;C4732255		TBP (TATA box binding protein) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles
81345	SourceAtomCluster	81345	False	False	CPT	6	0					NONE	NONE		NONE	C4732258;C4732257;C4732260;C5412197		TERT (telomerase reverse transcriptase) (eg, thyroid carcinoma, glioblastoma multiforme) gene analysis, targeted sequence analysis (eg, promoter region)
81346	SourceAtomCluster	81346	False	False	CPT	6	0					NONE	NONE		NONE	C4523524;C3708796		TYMS (thymidylate synthetase) (eg, 5-fluorouracil/5-FU drug metabolism), gene analysis, common variant(s) (eg, tandem repeat variant)
81347	SourceAtomCluster	81347	False	False	CPT	6	0					NONE	NONE		NONE	C5412198;C5412201;C5412200;C5412199		SF3B1 (splicing factor [3b] subunit B1) (eg, myelodysplastic syndrome/acute myeloid leukemia) gene analysis, common variants (eg, A672T, E622D, L833F, R625C, R625L)
81348	SourceAtomCluster	81348	False	False	CPT	6	0					NONE	NONE		NONE	C5412203;C5412204;C5412202;C5412205		SRSF2 (serine and arginine-rich splicing factor 2) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (eg, P95H, P95L)
81349	SourceAtomCluster	81349	False	False	CPT	5	0					NONE	NONE		NONE	C5691487;C5696515;C5697873		Cytogenomic (genome-wide) analysis for constitutional chromosomal abnormalities; interrogation of genomic regions for copy number and loss-of-heterozygosity variants, low-pass sequencing analysis
81350	SourceAtomCluster	81350	False	False	CPT	7	0					NONE	NONE		NONE	C3248203;C5201988;C3708506;C3708507		UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) (eg, drug metabolism, hereditary unconjugated hyperbilirubinemia [Gilbert syndrome]) gene analysis, common variants (eg, *28, *36, *37)
81351	SourceAtomCluster	81351	False	False	CPT	5	0					NONE	NONE		NONE	C5412207;C5412208;C5412209		TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; full gene sequence
81352	SourceAtomCluster	81352	False	False	CPT	6	0					NONE	NONE		NONE	C5412210;C5412212;C5412211;C5412213		TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; targeted sequence analysis (eg, 4 oncology)
81353	SourceAtomCluster	81353	False	False	CPT	5	0					NONE	NONE		NONE	C5412214;C5412216;C5412215		TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; known familial variant
81355	SourceAtomCluster	81355	False	False	CPT	7	0					NONE	NONE		NONE	C3516274;C3525657;C5412217;C5412218;C3248204		VKORC1 (vitamin K epoxide reductase complex, subunit 1) (eg, warfarin metabolism), gene analysis, common variant(s) (eg, -1639G>A, c.173+1000C>T)
81357	SourceAtomCluster	81357	False	False	CPT	6	0					NONE	NONE		NONE	C5412220;C5412222;C5412219;C5412221		U2AF1 (U2 small nuclear RNA auxiliary factor 1) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (eg, S34F, S34Y, Q157R, Q157P)
81360	SourceAtomCluster	81360	False	False	CPT	6	0					NONE	NONE		NONE	C5412223;C5412225;C5412226;C5412224		ZRSR2 (zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variant(s) (eg, E65fs, E122fs, R448fs)
81361	SourceAtomCluster	81361	False	False	CPT	9	0					NONE	NONE		NONE	C4523526;C4523530;C4523527;C4523528;C4523529;C5412227		HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); common variant(s) (eg, HbS, HbC, HbE)
81362	SourceAtomCluster	81362	False	False	CPT	5	0					NONE	NONE		NONE	C4523531;C4523532		HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); known familial variant(s)
81363	SourceAtomCluster	81363	False	False	CPT	5	0					NONE	NONE		NONE	C4523534;C4523533		HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); duplication/deletion variant(s)
81364	SourceAtomCluster	81364	False	False	CPT	5	0					NONE	NONE		NONE	C4523536;C4523537;C4523535		HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); full gene sequence
81370	SourceAtomCluster	81370	False	False	CPT	5	0					NONE	NONE		NONE	C3248205		HLA Class I and II typing, low resolution (eg, antigen equivalents); HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1
81371	SourceAtomCluster	81371	False	False	CPT	5	0					NONE	NONE		NONE	C3248206;C3703938		HLA Class I and II typing, low resolution (eg, antigen equivalents); HLA-A, -B, and -DRB1 (eg, verification typing)
81372	SourceAtomCluster	81372	False	False	CPT	5	0					NONE	NONE		NONE	C3516275;C5412228;C3248207		HLA Class I typing, low resolution (eg, antigen equivalents); complete (ie, HLA-A, -B, and -C)
81373	SourceAtomCluster	81373	False	False	CPT	8	0					NONE	NONE		NONE	C5412229;C3248208;C3708510;C3708511;C3708509		HLA Class I typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-A, -B, or -C), each
81374	SourceAtomCluster	81374	False	False	CPT	6	0					NONE	NONE		NONE	C5412230;C3248209;C3708512		HLA Class I typing, low resolution (eg, antigen equivalents); one antigen equivalent (eg, B*27), each
81375	SourceAtomCluster	81375	False	False	CPT	5	0					NONE	NONE		NONE	C3248210		HLA Class II typing, low resolution (eg, antigen equivalents); HLA-DRB1/3/4/5 and -DQB1
81376	SourceAtomCluster	81376	False	False	CPT	11	0					NONE	NONE		NONE	C5412231;C5412232;C3248211;C3708514;C3516277;C3525663;C3708515;C3708513;C5412233		HLA Class II typing, low resolution (eg, antigen equivalents); one locus (eg, HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), each
81377	SourceAtomCluster	81377	False	False	CPT	5	0					NONE	NONE		NONE	C3248212;C5412234		HLA Class II typing, low resolution (eg, antigen equivalents); one antigen equivalent, each
81378	SourceAtomCluster	81378	False	False	CPT	5	0					NONE	NONE		NONE	C3248213;C5412235		HLA Class I and II typing, high resolution (ie, alleles or allele groups), HLA-A, -B, -C, and -DRB1
81379	SourceAtomCluster	81379	False	False	CPT	5	0					NONE	NONE		NONE	C3248214;C3516278;C5412236		HLA Class I typing, high resolution (ie, alleles or allele groups); complete (ie, HLA-A, -B, and -C)
81380	SourceAtomCluster	81380	False	False	CPT	8	0					NONE	NONE		NONE	C3248215;C3516279;C5412237;C3708516;C3708517;C3708518		HLA Class I typing, high resolution (ie, alleles or allele groups); one locus (eg, HLA-A, -B, or -C), each
81381	SourceAtomCluster	81381	False	False	CPT	7	0					NONE	NONE		NONE	C3248216;C5412238;C5412239		HLA Class I typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, B*57:01P), each
81382	SourceAtomCluster	81382	False	False	CPT	11	0					NONE	NONE		NONE	C5412241;C3248217;C3516280;C3708522;C3708519;C3708521;C3708523;C5412240;C3708520		HLA Class II typing, high resolution (ie, alleles or allele groups); one locus (eg, HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1), each
81383	SourceAtomCluster	81383	False	False	CPT	7	0					NONE	NONE		NONE	C5412242;C3248218;C3708527;C5412243		HLA Class II typing, high resolution (ie, alleles or allele groups); one allele or allele group (eg, HLA-DQB1*06:02P), each
81400	SourceAtomCluster	81400	False	False	CPT	83	0					NONE	NONE		NONE	C5412247;C5412248;C5412251;C5412255;C5412259;C5412260;C5412271;C5412272;C5412275;C5412278;C5412284;C5412288;C5412290;C5412297;C5412298;C5412303;C5412305;C5412309;C5412310;C5412312;C5412313;C5412317;C5412318;C5412245;C5412250		Molecular pathology procedure, Level 1
81401	SourceAtomCluster	81401	False	False	CPT	172	0					NONE	NONE		NONE	C5412324;C5412337;C5412338;C5412342;C5412344;C5412364;C5412368;C5412383;C5412396;C5412397;C5412414;C5412415;C5412419;C5412426;C5412430;C5412439;C5412445;C5412447;C5412451;C5412459;C5412462;C5412473;C5412475;C5412478;C5412323		Molecular pathology procedure, Level 2
81402	SourceAtomCluster	81402	False	False	CPT	52	0					NONE	NONE		NONE	C5412493;C5412495;C5412503;C5412504;C5412509;C5412515;C5412517;C5412519;C5412520;C5412526;C5412534;C5412489;C5412497;C5412501;C5412502;C5412507;C5412512;C5412524;C5412535;C3248221;C5412492;C5412508;C5412510;C5412511;C5412527		Molecular pathology procedure, Level 3
81403	SourceAtomCluster	81403	False	False	CPT	254	0					NONE	NONE		NONE	C5412537;C5412539;C5412543;C5412545;C5412546;C5412553;C5412555;C5412565;C5412566;C5412576;C5412583;C5412586;C5412590;C5412592;C5412595;C5412598;C5412540;C5412549;C5412554;C5412558;C5412567;C5412568;C5412569;C5412572;C5412575		Molecular pathology procedure, Level 4
81404	SourceAtomCluster	81404	False	False	CPT	317	0					NONE	NONE		NONE	C5850913;C5850914;C5850915;C5850920;C5850925;C5850926;C5850927;C5850928;C5850936;C5850943;C5850949;C5850951;C5850959;C5850973;C5850975;C5850976;C5850985;C5850986;C5850996;C5850997;C5850999;C5851005;C5851007;C5851010;C5851011		Molecular pathology procedure, Level 5
81405	SourceAtomCluster	81405	False	False	CPT	419	0					NONE	NONE		NONE	C5851097;C5851098;C5851103;C5851105;C5851108;C5851129;C5851135;C5851136;C5851138;C5851140;C5851142;C5851143;C5851144;C5851150;C5851153;C5851161;C5851189;C5851197;C5851202;C5851213;C5851214;C5851215;C5851216;C5851220;C5851221		Molecular pathology procedure, Level 6
81406	SourceAtomCluster	81406	False	False	CPT	377	0					NONE	NONE		NONE	C5851325;C5851328;C5851345;C5851346;C5851352;C5851356;C5851359;C5851366;C5851367;C5851369;C5851370;C5851382;C5851383;C5851399;C5851405;C5851407;C5851424;C5851428;C5851429;C5851433;C5851435;C5851439;C5851440;C5851446;C5851447		Molecular pathology procedure, Level 7
81407	SourceAtomCluster	81407	False	False	CPT	99	0					NONE	NONE		NONE	C5851632;C5851633;C5851639;C5851640;C5851643;C5851659;C5851664;C5851672;C5851685;C5851686;C5851691;C5851693;C5851695;C5851696;C5851698;C5851699;C5851702;C5851706;C5851650;C5851661;C5851662;C5851663;C5851668;C5851670;C5851673		Molecular pathology procedure, Level 8
81408	SourceAtomCluster	81408	False	False	CPT	63	0					NONE	NONE		NONE	C5851712;C5851718;C5851721;C5851723;C5851727;C5851739;C5851742;C5851755;C5851756;C5851711;C5851714;C5851717;C5851722;C5851724;C5851729;C5851737;C5851738;C5851741;C5851751;C5851709;C5851719;C5851725;C5851726;C5851728;C5851732		Molecular pathology procedure, Level 9
81410	SourceAtomCluster	81410	False	False	CPT	6	0					NONE	NONE		NONE	C5413180;C3860192;C5413182;C5413181		Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome); genomic sequence analysis panel, must include sequencing of at least 9 genes, including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK
81411	SourceAtomCluster	81411	False	False	CPT	6	0					NONE	NONE		NONE	C3864988;C5413183;C5413185;C5413184		Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos syndrome type IV, arterial tortuosity syndrome); duplication/deletion analysis panel, must include analyses for TGFBR1, TGFBR2, MYH11, and COL3A1
81412	SourceAtomCluster	81412	False	False	CPT	5	0					NONE	NONE		NONE	C4051855;C5413187;C5413186		Ashkenazi Jewish associated disorders (eg, Bloom syndrome, Canavan disease, cystic fibrosis, familial dysautonomia, Fanconi anemia group C, Gaucher disease, Tay-Sachs disease), genomic sequence analysis panel, must include sequencing of at least 9 genes, including ASPA, BLM, CFTR, FANCC, GBA, HEXA, IKBKAP, MCOLN1, and SMPD1
81413	SourceAtomCluster	81413	False	False	CPT	5	0					NONE	NONE		NONE	C4291784;C5413189;C5413188		Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); genomic sequence analysis panel, must include sequencing of at least 10 genes, including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, KCNJ2, KCNQ1, RYR2, and SCN5A
81414	SourceAtomCluster	81414	False	False	CPT	5	0					NONE	NONE		NONE	C4291785;C5413190;C5413191		Cardiac ion channelopathies (eg, Brugada syndrome, long QT syndrome, short QT syndrome, catecholaminergic polymorphic ventricular tachycardia); duplication/deletion gene analysis panel, must include analysis of at least 2 genes, including KCNH2 and KCNQ1
81415	SourceAtomCluster	81415	False	False	CPT	5	0					NONE	NONE		NONE	C3865504;C3854132;C3854133		Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis
81416	SourceAtomCluster	81416	False	False	CPT	5	0					NONE	NONE		NONE	C3854140;C5413192		Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis, each comparator exome (eg, parents, siblings) (List separately in addition to code for primary procedure)
81417	SourceAtomCluster	81417	False	False	CPT	5	0					NONE	NONE		NONE	C3865328;C3865511;C5413193		Exome (eg, unexplained constitutional or heritable disorder or syndrome); re-evaluation of previously obtained exome sequence (eg, updated knowledge or unrelated condition/syndrome)
81418	SourceAtomCluster	81418	False	False	CPT	5	0					NONE	NONE		NONE	C5702047		Drug metabolism (eg, pharmacogenomics) genomic sequence analysis panel, must include testing of at least 6 genes, including CYP2C19, CYP2D6, and CYP2D6 duplication/deletion analysis
81419	SourceAtomCluster	81419	False	False	CPT	5	0					NONE	NONE		NONE	C5413195;C5413194;C5413196		Epilepsy genomic sequence analysis panel, must include analyses for ALDH7A1, CACNA1A, CDKL5, CHD2, GABRG2, GRIN2A, KCNQ2, MECP2, PCDH19, POLG, PRRT2, SCN1A, SCN1B, SCN2A, SCN8A, SLC2A1, SLC9A6, STXBP1, SYNGAP1, TCF4, TPP1, TSC1, TSC2, and ZEB2
81420	SourceAtomCluster	81420	False	False	CPT	5	0					NONE	NONE		NONE	C3865327;C3865512;C5413197		Fetal chromosomal aneuploidy (eg, trisomy 21, monosomy X) genomic sequence analysis panel, circulating cell-free fetal DNA in maternal blood, must include analysis of chromosomes 13, 18, and 21
81422	SourceAtomCluster	81422	False	False	CPT	5	0					NONE	NONE		NONE	C4291786;C5413198		Fetal chromosomal microdeletion(s) genomic sequence analysis (eg, DiGeorge syndrome, Cri-du-chat syndrome), circulating cell-free fetal DNA in maternal blood
81425	SourceAtomCluster	81425	False	False	CPT	5	0					NONE	NONE		NONE	C3854164;C5413199		Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis
81426	SourceAtomCluster	81426	False	False	CPT	5	0					NONE	NONE		NONE	C3854163;C5413200;C5413201		Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis, each comparator genome (eg, parents, siblings) (List separately in addition to code for primary procedure)
81427	SourceAtomCluster	81427	False	False	CPT	5	0					NONE	NONE		NONE	C3865326;C5413203;C5413202		Genome (eg, unexplained constitutional or heritable disorder or syndrome); re-evaluation of previously obtained genome sequence (eg, updated knowledge or unrelated condition/syndrome)
81430	SourceAtomCluster	81430	False	False	CPT	5	0					NONE	NONE		NONE	C3865325;C5413204;C5413205		Hearing loss (eg, nonsyndromic hearing loss, Usher syndrome, Pendred syndrome); genomic sequence analysis panel, must include sequencing of at least 60 genes, including CDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3, USH1C, USH1G, USH2A, and WFS1
81431	SourceAtomCluster	81431	False	False	CPT	5	0					NONE	NONE		NONE	C3865324;C3865510;C5413206		Hearing loss (eg, nonsyndromic hearing loss, Usher syndrome, Pendred syndrome); duplication/deletion analysis panel, must include copy number analyses for STRC and DFNB1 deletions in GJB2 and GJB6 genes
81432	SourceAtomCluster	81432	False	False	CPT	5	0					NONE	NONE		NONE	C4050039;C5944546		Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer, hereditary pancreatic cancer, hereditary prostate cancer), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants
81433																		
81434	SourceAtomCluster	81434	False	False	CPT	5	0					NONE	NONE		NONE	C4051854;C4051957;C5413209		Hereditary retinal disorders (eg, retinitis pigmentosa, Leber congenital amaurosis, cone-rod dystrophy), genomic sequence analysis panel, must include sequencing of at least 15 genes, including ABCA4, CNGA1, CRB1, EYS, PDE6A, PDE6B, PRPF31, PRPH2, RDH12, RHO, RP1, RP2, RPE65, RPGR, and USH2A
81435	SourceAtomCluster	81435	False	False	CPT	5	0					NONE	NONE		NONE	C4050035;C5944547		Hereditary colon cancer-related disorders (eg, Lynch syndrome, PTEN hamartoma syndrome, Cowden syndrome, familial adenomatosis polyposis), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants
81436																		
81437	SourceAtomCluster	81437	False	False	CPT	5	0					NONE	NONE		NONE	C4050037;C5944548		Hereditary neuroendocrine tumor-related disorders (eg, medullary thyroid carcinoma, parathyroid carcinoma, malignant pheochromocytoma or paraganglioma), genomic sequence analysis panel, 5 or more genes, interrogation for sequence variants and copy number variants
81438																		
81439	SourceAtomCluster	81439	False	False	CPT	5	0					NONE	NONE		NONE	C4291787;C4292006;C5413215		Hereditary cardiomyopathy (eg, hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy), genomic sequence analysis panel, must include sequencing of at least 5 cardiomyopathy-related genes (eg, DSG2, MYBPC3, MYH7, PKP2, TTN)
81440	SourceAtomCluster	81440	False	False	CPT	5	0					NONE	NONE		NONE	C3854169;C5413216;C3865508		Nuclear encoded mitochondrial genes (eg, neurologic or myopathic phenotypes), genomic sequence panel, must include analysis of at least 100 genes, including BCS1L, C10orf2, COQ2, COX10, DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2, and TYMP
81442	SourceAtomCluster	81442	False	False	CPT	5	0					NONE	NONE		NONE	C5413217;C4051955;C4051853		Noonan spectrum disorders (eg, Noonan syndrome, cardio-facio-cutaneous syndrome, Costello syndrome, LEOPARD syndrome, Noonan-like syndrome), genomic sequence analysis panel, must include sequencing of at least 12 genes, including BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, and SOS1
81443	SourceAtomCluster	81443	False	False	CPT	5	0					NONE	NONE		NONE	C4732262;C5413218;C4732261		Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)
81445	SourceAtomCluster	81445	False	False	CPT	8	0					NONE	NONE		NONE	C5851759;C3854311;C5851760;C5851763;C5851761;C5851762		Solid organ neoplasm, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants and copy number variants or rearrangements, if performed; DNA analysis or combined DNA and RNA analysis
81448	SourceAtomCluster	81448	False	False	CPT	5	0					NONE	NONE		NONE	C4523544;C4523545;C5413221		Hereditary peripheral neuropathies (eg, Charcot-Marie-Tooth, spastic paraplegia), genomic sequence analysis panel, must include sequencing of at least 5 peripheral neuropathy-related genes (eg, BSCL2, GJB1, MFN2, MPZ, REEP1, SPAST, SPG11, SPTLC1)
81450	SourceAtomCluster	81450	False	False	CPT	12	0					NONE	NONE		NONE	C5851772;C5851774;C5851770;C5851775;C3854310;C5851768;C5851769;C5851771;C5851773;C5851776		Hematolymphoid neoplasm or disorder, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; DNA analysis or combined DNA and RNA analysis
81451	SourceAtomCluster	81451	False	False	CPT	7	0					NONE	NONE		NONE	C5851777;C5702068;C5851778;C5851780;C5851779		Hematolymphoid neoplasm or disorder, genomic sequence analysis panel, 5-50 genes, interrogation for sequence variants, and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; RNA analysis
81455	SourceAtomCluster	81455	False	False	CPT	12	0					NONE	NONE		NONE	C5851786;C5851788;C3854309;C5851782;C5851789;C5851790;C5851783;C5851784;C5851785;C5851787		Solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes, genomic sequence analysis panel, interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; DNA analysis or combined DNA and RNA analysis
81456	SourceAtomCluster	81456	False	False	CPT	7	0					NONE	NONE		NONE	C5851794;C5702082;C5851792;C5851793;C5851791		Solid organ or hematolymphoid neoplasm or disorder, 51 or greater genes, genomic sequence analysis panel, interrogation for sequence variants and copy number variants or rearrangements, or isoform expression or mRNA expression levels, if performed; RNA analysis
81460	SourceAtomCluster	81460	False	False	CPT	5	0					NONE	NONE		NONE	C3854318;C5413231;C5413230		Whole mitochondrial genome (eg, Leigh syndrome, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes [MELAS], myoclonic epilepsy with ragged-red fibers [MERFF], neuropathy, ataxia, and retinitis pigmentosa [NARP], Leber hereditary optic neuropathy [LHON]), genomic sequence, must include sequence analysis of entire mitochondrial genome with heteroplasmy detection
81465	SourceAtomCluster	81465	False	False	CPT	6	0					NONE	NONE		NONE	C3854316;C5413232;C5413233;C5413234		Whole mitochondrial genome large deletion analysis panel (eg, Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia), including heteroplasmy detection, if performed
81470	SourceAtomCluster	81470	False	False	CPT	5	0					NONE	NONE		NONE	C3854319;C3865503;C5413235		X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); genomic sequence analysis panel, must include sequencing of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2
81471	SourceAtomCluster	81471	False	False	CPT	5	0					NONE	NONE		NONE	C3854320;C5413236;C5413237		X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); duplication/deletion gene analysis, must include analysis of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2
81479	SourceAtomCluster	81479	False	False	CPT	5	0					NONE	NONE		NONE	C3511555;C3248361		Unlisted molecular pathology procedure
81490	SourceAtomCluster	81490	False	False	CPT	5	0					NONE	NONE		NONE	C4051852;C5413238;C4051954		Autoimmune (rheumatoid arthritis), analysis of 12 biomarkers using immunoassays, utilizing serum, prognostic algorithm reported as a disease activity score
81493	SourceAtomCluster	81493	False	False	CPT	5	0					NONE	NONE		NONE	C4051953;C4051851;C5413239		Coronary artery disease, mRNA, gene expression profiling by real-time RT-PCR of 23 genes, utilizing whole peripheral blood, algorithm reported as a risk score
81500	SourceAtomCluster	81500	False	False	CPT	5	0					NONE	NONE		NONE	C3511556;C3703939;C5413240		Oncology (ovarian), biochemical assays of two proteins (CA-125 and HE4), utilizing serum, with menopausal status, algorithm reported as a risk score
81503	SourceAtomCluster	81503	False	False	CPT	5	0					NONE	NONE		NONE	C3511557;C5413241;C5413242		Oncology (ovarian), biochemical assays of five proteins (CA-125, apolipoprotein A1, beta-2 microglobulin, transferrin, and pre-albumin), utilizing serum, algorithm reported as a risk score
81504	SourceAtomCluster	81504	False	False	CPT	5	0					NONE	NONE		NONE	C5413243;C3703940;C3702509		Oncology (tissue of origin), microarray gene expression profiling of > 2000 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as tissue similarity scores
81506	SourceAtomCluster	81506	False	False	CPT	6	0					NONE	NONE		NONE	C3511558;C5413244;C5413245		Endocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, HbA1c, insulin, hs-CRP, adiponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithm reporting a risk score
81507	SourceAtomCluster	81507	False	False	CPT	5	0					NONE	NONE		NONE	C3703941;C5413246;C3702510		Fetal aneuploidy (trisomy 21, 18, and 13) DNA sequence analysis of selected regions using maternal plasma, algorithm reported as a risk score for each trisomy
81508	SourceAtomCluster	81508	False	False	CPT	5	0					NONE	NONE		NONE	C3511559;C5413247		Fetal congenital abnormalities, biochemical assays of two proteins (PAPP-A, hCG [any form]), utilizing maternal serum, algorithm reported as a risk score
81509	SourceAtomCluster	81509	False	False	CPT	5	0					NONE	NONE		NONE	C3511560;C5413248		Fetal congenital abnormalities, biochemical assays of three proteins (PAPP-A, hCG [any form], DIA), utilizing maternal serum, algorithm reported as a risk score
81510	SourceAtomCluster	81510	False	False	CPT	5	0					NONE	NONE		NONE	C3511561;C5413249		Fetal congenital abnormalities, biochemical assays of three analytes (AFP, uE3, hCG [any form]), utilizing maternal serum, algorithm reported as a risk score
81511	SourceAtomCluster	81511	False	False	CPT	5	0					NONE	NONE		NONE	C5413250;C3511562		Fetal congenital abnormalities, biochemical assays of four analytes (AFP, uE3, hCG [any form], DIA) utilizing maternal serum, algorithm reported as a risk score (may include additional results from previous biochemical testing)
81512	SourceAtomCluster	81512	False	False	CPT	5	0					NONE	NONE		NONE	C3511652;C5413251		Fetal congenital abnormalities, biochemical assays of five analytes (AFP, uE3, total hCG, hyperglycosylated hCG, DIA) utilizing maternal serum, algorithm reported as a risk score
81513	SourceAtomCluster	81513	False	False	CPT	5	0					NONE	NONE		NONE	C5413253;C5413254;C5413252		Infectious disease, bacterial vaginosis, quantitative real-time amplification of RNA markers for Atopobium vaginae, Gardnerella vaginalis, and Lactobacillus species, utilizing vaginal-fluid specimens, algorithm reported as a positive or negative result for bacterial vaginosis
81514	SourceAtomCluster	81514	False	False	CPT	5	0					NONE	NONE		NONE	C5413255;C5413257;C5413256		Infectious disease, bacterial vaginosis and vaginitis, quantitative real-time amplification of DNA markers for Gardnerella vaginalis, Atopobium vaginae, Megasphaera type 1, Bacterial Vaginosis Associated Bacteria-2 (BVAB-2), and Lactobacillus species (L. crispatus and L. jensenii), utilizing vaginal-fluid specimens, algorithm reported as a positive or negative for high likelihood of bacterial vaginosis, includes separate detection of Trichomonas vaginalis and/or Candida species (C. albicans, C. tropicalis, C. parapsilosis, C. dubliniensis), Candida glabrata, Candida krusei, when reported
81518	SourceAtomCluster	81518	False	False	CPT	5	0					NONE	NONE		NONE	C4732264;C4722667;C5413258		Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 11 genes (7 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithms reported as percentage risk for metastatic recurrence and likelihood of benefit from extended endocrine therapy
81519	SourceAtomCluster	81519	False	False	CPT	5	0					NONE	NONE		NONE	C3865321;C3865502;C5413259		Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 21 genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence score
81520	SourceAtomCluster	81520	False	False	CPT	5	0					NONE	NONE		NONE	C4523547;C5413260		Oncology (breast), mRNA gene expression profiling by hybrid capture of 58 genes (50 content and 8 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence risk score
81521	SourceAtomCluster	81521	False	False	CPT	6	0					NONE	NONE		NONE	C4523551;C4523550;C4523548;C5413261		Oncology (breast), mRNA, microarray gene expression profiling of 70 content genes and 465 housekeeping genes, utilizing fresh frozen or formalin-fixed paraffin-embedded tissue, algorithm reported as index related to risk of distant metastasis
81522	SourceAtomCluster	81522	False	False	CPT	5	0					NONE	NONE		NONE	C5202002;C5202001;C5413262		Oncology (breast), mRNA, gene expression profiling by RT-PCR of 12 genes (8 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence risk score
81523	SourceAtomCluster	81523	False	False	CPT	5	0					NONE	NONE		NONE	C5691488;C5697885;C5696517		Oncology (breast), mRNA, next-generation sequencing gene expression profiling of 70 content genes and 31 housekeeping genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as index related to risk to distant metastasis
81525	SourceAtomCluster	81525	False	False	CPT	5	0					NONE	NONE		NONE	C4051850;C4051952;C5413263		Oncology (colon), mRNA, gene expression profiling by real-time RT-PCR of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a recurrence score
81528	SourceAtomCluster	81528	False	False	CPT	5	0					NONE	NONE		NONE	C4051849;C4051914;C5413264		Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result
81529	SourceAtomCluster	81529	False	False	CPT	5	0					NONE	NONE		NONE	C5696518;C5413267;C5413265		Oncology (cutaneous melanoma), mRNA, gene expression profiling by real-time RT-PCR of 31 genes (28 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence risk, including likelihood of sentinel lymph node metastasis
81535	SourceAtomCluster	81535	False	False	CPT	5	0					NONE	NONE		NONE	C4049952;C5413269;C5413268		Oncology (gynecologic), live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as a drug response score; first single drug or drug combination
81536	SourceAtomCluster	81536	False	False	CPT	6	0					NONE	NONE		NONE	C5413270;C5413271;C4051951;C4049951		Oncology (gynecologic), live tumor cell culture and chemotherapeutic response by DAPI stain and morphology, predictive algorithm reported as a drug response score; each additional single drug or drug combination (List separately in addition to code for primary procedure)
81538	SourceAtomCluster	81538	False	False	CPT	5	0					NONE	NONE		NONE	C4051848;C4051950;C5413272		Oncology (lung), mass spectrometric 8-protein signature, including amyloid A, utilizing serum, prognostic and predictive algorithm reported as good versus poor overall survival
81539	SourceAtomCluster	81539	False	False	CPT	6	0					NONE	NONE		NONE	C4291788;C4292324;C4292323;C4292007		Oncology (high-grade prostate cancer), biochemical assay of four proteins (Total PSA, Free PSA, Intact PSA, and human kallikrein-2 [hK2]), utilizing plasma or serum, prognostic algorithm reported as a probability score
81540	SourceAtomCluster	81540	False	False	CPT	5	0					NONE	NONE		NONE	C4051847;C5413273;C4051949		Oncology (tumor of unknown origin), mRNA, gene expression profiling by real-time RT-PCR of 92 genes (87 content and 5 housekeeping) to classify tumor into main cancer type and subtype, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a probability of a predicted main cancer type and subtype
81541	SourceAtomCluster	81541	False	False	CPT	5	0					NONE	NONE		NONE	C4523552;C4523553;C5413274		Oncology (prostate), mRNA gene expression profiling by real-time RT-PCR of 46 genes (31 content and 15 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a disease-specific mortality risk score
81542	SourceAtomCluster	81542	False	False	CPT	5	0					NONE	NONE		NONE	C5202004;C5202005;C5413275		Oncology (prostate), mRNA, microarray gene expression profiling of 22 content genes, utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as metastasis risk score
81546	SourceAtomCluster	81546	False	False	CPT	5	0					NONE	NONE		NONE	C5413277;C5413276;C5413278		Oncology (thyroid), mRNA, gene expression analysis of 10,196 genes, utilizing fine needle aspirate, algorithm reported as a categorical result (eg, benign or suspicious)
81551	SourceAtomCluster	81551	False	False	CPT	5	0					NONE	NONE		NONE	C4523555;C5413280;C5413279		Oncology (prostate), promoter methylation profiling by real-time PCR of 3 genes (GSTP1, APC, RASSF1), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a likelihood of prostate cancer detection on repeat biopsy
81552	SourceAtomCluster	81552	False	False	CPT	6	0					NONE	NONE		NONE	C5202007;C4746540;C5413282;C5413281		Oncology (uveal melanoma), mRNA, gene expression profiling by real-time RT-PCR of 15 genes (12 content and 3 housekeeping), utilizing fine needle aspirate or formalin-fixed paraffin-embedded tissue, algorithm reported as risk of metastasis
81554	SourceAtomCluster	81554	False	False	CPT	5	0					NONE	NONE		NONE	C5413283;C5413284;C5413285		Pulmonary disease (idiopathic pulmonary fibrosis [IPF]), mRNA, gene expression analysis of 190 genes, utilizing transbronchial biopsies, diagnostic algorithm reported as categorical result (eg, positive or negative for high probability of usual interstitial pneumonia [UIP])
81560	SourceAtomCluster	81560	False	False	CPT	5	0					NONE	NONE		NONE	C5691489;C5696519;C5697886		Transplantation medicine (allograft rejection, pediatric liver and small bowel), measurement of donor and third-party-induced CD154+T-cytotoxic memory cells, utilizing whole peripheral blood, algorithm reported as a rejection risk score
81595	SourceAtomCluster	81595	False	False	CPT	5	0					NONE	NONE		NONE	C4051845;C3865513;C5413286		Cardiology (heart transplant), mRNA, gene expression profiling by real-time quantitative PCR of 20 genes (11 content and 9 housekeeping), utilizing subfraction of peripheral blood, algorithm reported as a rejection risk score
81596	SourceAtomCluster	81596	False	False	CPT	5	0					NONE	NONE		NONE	C4732266;C4732267;C5413287		Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver
81599	SourceAtomCluster	81599	False	False	CPT	5	0					NONE	NONE		NONE	C3511563;C3516281		Unlisted multianalyte assay with algorithmic analysis
88245	SourceAtomCluster	88245	False	False	CPT	5	0					NONE	NONE		NONE	C0200878;C5414247;C5414246		Chromosome analysis for breakage syndromes; baseline Sister Chromatid Exchange (SCE), 20-25 cells
88248	SourceAtomCluster	88248	False	False	CPT	5	0					NONE	NONE		NONE	C0200879;C5414249;C5414248		Chromosome analysis for breakage syndromes; baseline breakage, score 50-100 cells, count 20 cells, 2 karyotypes (eg, for ataxia telangiectasia, Fanconi anemia, fragile X)
88249	SourceAtomCluster	88249	False	False	CPT	5	0					NONE	NONE		NONE	C0695100;C5414250;C2074584		Chromosome analysis for breakage syndromes; score 100 cells, clastogen stress (eg, diepoxybutane, mitomycin C, ionizing radiation, UV radiation)
88261	SourceAtomCluster	88261	False	False	CPT	5	0					NONE	NONE		NONE	C0200882;C5414251		Chromosome analysis; count 5 cells, 1 karyotype, with banding
88262	SourceAtomCluster	88262	False	False	CPT	5	0					NONE	NONE		NONE	C0200883;C5414252		Chromosome analysis; count 15-20 cells, 2 karyotypes, with banding
88263	SourceAtomCluster	88263	False	False	CPT	5	0					NONE	NONE		NONE	C0200884;C5414253;C5414254		Chromosome analysis; count 45 cells for mosaicism, 2 karyotypes, with banding
88264	SourceAtomCluster	88264	False	False	CPT	5	0					NONE	NONE		NONE	C2125445;C0695101;C5414255		Chromosome analysis; analyze 20-25 cells
88267	SourceAtomCluster	88267	False	False	CPT	6	0					NONE	NONE		NONE	C0200885;C5414257;C3516642;C5414256		Chromosome analysis, amniotic fluid or chorionic villus, count 15 cells, 1 karyotype, with banding
88269	SourceAtomCluster	88269	False	False	CPT	5	0					NONE	NONE		NONE	C0200886;C5414258;C3516643		Chromosome analysis, in situ for amniotic fluid cells, count cells from 6-12 colonies, 1 karyotype, with banding
88271	SourceAtomCluster	88271	False	False	CPT	5	0					NONE	NONE		NONE	C3516644;C0695102;C5414259		Molecular cytogenetics; DNA probe, each (eg, FISH)
88272	SourceAtomCluster	88272	False	False	CPT	5	0					NONE	NONE		NONE	C0695103;C3516641;C5414260		Molecular cytogenetics; chromosomal in situ hybridization, analyze 3-5 cells (eg, for derivatives and markers)
88273	SourceAtomCluster	88273	False	False	CPT	5	0					NONE	NONE		NONE	C5414261;C0695104;C5414262		Molecular cytogenetics; chromosomal in situ hybridization, analyze 10-30 cells (eg, for microdeletions)
88274	SourceAtomCluster	88274	False	False	CPT	5	0					NONE	NONE		NONE	C0695105;C5414263;C5414264		Molecular cytogenetics; interphase in situ hybridization, analyze 25-99 cells
88275	SourceAtomCluster	88275	False	False	CPT	5	0					NONE	NONE		NONE	C0695106;C5414266;C5414265		Molecular cytogenetics; interphase in situ hybridization, analyze 100-300 cells
88280	SourceAtomCluster	88280	False	False	CPT	5	0					NONE	NONE		NONE	C0200887;C5416766;C2121012		Chromosome analysis; additional karyotypes, each study
88283	SourceAtomCluster	88283	False	False	CPT	5	0					NONE	NONE		NONE	C2121013;C0374075;C5414267		Chromosome analysis; additional specialized banding technique (eg, NOR, C-banding)
88285	SourceAtomCluster	88285	False	False	CPT	5	0					NONE	NONE		NONE	C0200891;C2121014;C5414268		Chromosome analysis; additional cells counted, each study
88289	SourceAtomCluster	88289	False	False	CPT	5	0					NONE	NONE		NONE	C0200892;C5414269		Chromosome analysis; additional high resolution study
88371	SourceAtomCluster	88371	False	False	CPT	5	0					NONE	NONE		NONE	C3516669;C0374090		Protein analysis of tissue by Western Blot, with interpretation and report
88372	SourceAtomCluster	88372	False	False	CPT	5	0					NONE	NONE		NONE	C0374090;C0374091;C5414334		Protein analysis of tissue by Western Blot, with interpretation and report; immunological probe for band identification, each
G0452																		
G9143																		
